Across numerous clinical trials spanning Early Phase 1 through Phase 4, busulfan has been extensively evaluated in conditioning regimens for hematopoietic stem cell transplantation. These studies target conditions such as acute myeloid leukemia, myelodysplastic syndrome, severe immunodeficiencies, and neuroblastoma, with recruitment statuses ranging from recruiting and completed to active not recruiting and terminated. Spearheaded by diverse sponsors—including the Fred Hutchinson Cancer Center, the National Institute of Allergy and Infectious Diseases, and Great Ormond Street Hospital for Children—this research encompasses targeted pharmacokinetic and gene therapy protocols.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT03538899 | RECRUITING | Severe Combined Immunodeficiency |
University of California, San Francisco |
2018-05-31 | PHASE1; PHASE2 |
| NCT06851767 | ENROLLING_BY_INVITATION | X-linked Severe Combined Immunodeficiency; X-SCID; XSCID |
National Institute of Allergy and Infectious Diseases (NIAID) |
2025-05-09 | PHASE1; PHASE2 |
| NCT07524530 | NOT_YET_RECRUITING | Core Binding Factor Alpha Subunits; Hematologic Neoplasms; Leukemia; Lymphoma |
National Cancer Institute (NCI) |
2026-09-09 | PHASE2 |
| NCT05565105 | NOT_YET_RECRUITING | Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Acute |
Guenther Koehne |
2026-06 | PHASE2 |
| NCT05617625 | SUSPENDED | Myelodysplastic Syndromes; Graft Vs Host Disease; Graft-versus-host-disease |
Guenther Koehne |
2026-06 | PHASE2 |
| NCT01306019 | RECRUITING | X-linked Severe Combined Immunodeficiency (XSCID) |
National Institute of Allergy and Infectious Diseases (NIAID) |
2012-09-25 | PHASE1; PHASE2 |
| NCT06325709 | RECRUITING | Chronic Granulomatous Disease (CGD); X-Linked Chronic Granulomatous Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
2024-04-17 | PHASE1; PHASE2 |
| NCT05463133 | RECRUITING | Chronic Granulomatous Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
2022-07-08 | PHASE1; PHASE2 |
| NCT07759102 | NOT_YET_RECRUITING | Recurrent Multiple Myeloma; Refractory Multiple Myeloma |
University of California, Davis |
2026-09-01 | PHASE1 |
| NCT04982354 | WITHDRAWN | Acute Myeloid Leukemia |
Guenther Koehne |
2022-07-05 | PHASE1; PHASE2 |
| NCT05027945 | RECRUITING | Immunodeficiency; Hematopoietic Stem Cell Transplantation |
National Cancer Institute (NCI) |
2023-02-23 | PHASE2 |
| NCT07228624 | RECRUITING | Myelodysplastic/Myeloproliferative Neoplasm; Primary Myelofibrosis; Secondary Myelofibrosis |
Fred Hutchinson Cancer Center |
2026-02-04 | PHASE2 |
| NCT07792369 | NOT_YET_RECRUITING | Busulfan Pharmacokinetic Analysis; Busulfan Dosing; Hematopoietic Stem Cell Transplant (HSCT); Busulfan; Glutathione |
Children's Hospital of Philadelphia |
2026-09 | PHASE1 |
| NCT01949129 | RECRUITING | Acute Lymphoblastic Leukaemia |
St. Anna Kinderkrebsforschung |
2013-04 | PHASE2; PHASE3 |
| NCT06872333 | RECRUITING | Graft Failure; Sickle Cell Disease; Hemoglobinopathies |
Masonic Cancer Center, University of Minnesota |
2024-11-19 | PHASE2 |
| NCT07566377 | RECRUITING | Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Non-hodgkin Lymphoma; Hodgkin Lymphoma; Leukemia; Lymphoma; Graft-versus-host Disease |
Memorial Sloan Kettering Cancer Center |
2026-04-28 | PHASE2 |
| NCT04282174 | WITHDRAWN | Hematologic Diseases; Hematologic Malignancy; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia |
Baptist Health South Florida |
2022-09 | PHASE2 |
| NCT07074470 | RECRUITING | Primary Central Nervous System Lymphoma (PCNSL) |
The First Affiliated Hospital of Soochow University |
2025-01-02 | |
| NCT05477589 | RECRUITING | Acute Myeloid Leukemia (AML) in Remission; Stem Cell Transplantation |
Vastra Gotaland Region |
2022-06-07 | PHASE3 |
| NCT07644481 | NOT_YET_RECRUITING | AML (Acute Myelogenous Leukemia); Allogeneic Hematopoietic Stem Cell Transplantation Recipient |
Institute of Hematology & Blood Diseases Hospital, China |
2026-07-20 | |
| NCT07276737 | NOT_YET_RECRUITING | NK T-Cell Lymphoma |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2025-12-30 | PHASE2 |
| NCT06506461 | RECRUITING | Sickle Cell Disease |
St. Jude Children's Research Hospital |
2025-03-21 | PHASE1 |
| NCT06673459 | NOT_YET_RECRUITING | T-Cell Lymphocytic Leukemia; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; Total Body Irradiation; Chemotherapy |
The First Affiliated Hospital of Soochow University |
2024-12-01 | PHASE3 |
| NCT07762508 | NOT_YET_RECRUITING | Leukemia, Myeloid, Acute(AML); Hematopoietic Stem Cell Transplantation (HSCT) |
The First Affiliated Hospital of Soochow University |
2026-08 | |
| NCT07563920 | NOT_YET_RECRUITING | Acute Myeloid Leukemia |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2026-06 | |
| NCT07500753 | RECRUITING | Relapsed or Refractory Acute Myeloid Leukemia (AML); MDS (Myelodysplastic Syndrome) |
The First Affiliated Hospital of Soochow University |
2026-04-01 | |
| NCT03779854 | ACTIVE_NOT_RECRUITING | Acute Biphenotypic Leukemia; Acute Leukemia; Acute Leukemia of Ambiguous Lineage; Acute Lymphoblastic Leukemia; Acute Undifferentiated Leukemia; Allogeneic Hematopoietic Stem Cell Transplantation Recipient; Blastic Plasmacytoid Dendritic Cell Neoplasm; Blasts Under 25 Percent of Bone Marrow Nucleated Cells; Blasts Under 5 Percent of Bone Marrow Nucleated Cells; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome With Excess Blasts-1; Myelodysplastic Syndrome/Acute Myeloid Leukemia; Burkitt Leukemia; Chronic Monocytic Leukemia; Lymphoblastic Lymphoma; Mast Cell Leukemia; Myeloproliferative Neoplasm |
Fred Hutchinson Cancer Center |
2019-08-29 | PHASE2 |
| NCT07737769 | NOT_YET_RECRUITING | Acute Myeloid Leukemia; Myelodysplastic Syndrome |
University of Michigan Rogel Cancer Center |
2026-11 | PHASE1 |
| NCT06158828 | RECRUITING | AML, Childhood; Aml; Acute Myeloid Leukemia, Pediatric; Acute Myeloid Leukemia |
Washington University School of Medicine |
2024-11-15 | PHASE1; PHASE2 |
| NCT07113743 | ENROLLING_BY_INVITATION | Chronic Granulomatous Disease (CGD) |
National Institute of Allergy and Infectious Diseases (NIAID) |
2025-09-10 | PHASE1; PHASE2 |
| NCT02861417 | ACTIVE_NOT_RECRUITING | Hematopoietic and Lymphoid Cell Neoplasm; High Risk Acute Myeloid Leukemia; High Risk Myelodysplastic Syndrome; Lymphoproliferative Disorder; Myelodysplastic Syndrome; Myelodysplastic/Myeloproliferative Neoplasm; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Recurrent High Risk Myelodysplastic Syndrome; Recurrent Hodgkin Lymphoma; Recurrent Myelodysplastic Syndrome; Recurrent Non-Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma |
M.D. Anderson Cancer Center |
2016-08-05 | PHASE2 |
| NCT05327023 | RECRUITING | Hematologic Neoplasms |
National Cancer Institute (NCI) |
2022-05-23 | PHASE1; PHASE2 |
| NCT06477549 | RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Biphenotypic Acute Leukemia; Lymphoblastic Lymphoma; Myeloproliferative Neoplasm; Myelodysplastic Syndromes |
St. Petersburg State Pavlov Medical University |
2024-06-21 | PHASE2 |
| NCT06954987 | NOT_YET_RECRUITING | Acute Myeloid Leukemia |
National Cancer Institute (NCI) |
2026-07-17 | PHASE2 |
| NCT07085156 | NOT_YET_RECRUITING | MDS |
Ruijin Hospital |
2025-08-01 | PHASE2 |
| NCT04708054 | RECRUITING | Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2021-10-21 | PHASE2; PHASE3 |
| NCT07677306 | NOT_YET_RECRUITING | Myelodysplastic Syndromes |
Peking University People's Hospital |
2026-07-15 | PHASE2 |
| NCT07052422 | NOT_YET_RECRUITING | Older Patients; Myeloid Malignancies; Conditioning; Hematopoietic Stem Cell Transplantation (HSCT) |
Nanfang Hospital, Southern Medical University |
2025-07-15 | PHASE2; PHASE3 |
| NCT01861106 | RECRUITING | GATA2; Immunodeficiency; MDS |
National Cancer Institute (NCI) |
2013-07-24 | PHASE2 |
| NCT03970096 | RECRUITING | Acute Leukemia; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome; Myeloproliferative Neoplasm |
Fred Hutchinson Cancer Center |
2019-11-19 | PHASE2 |
| NCT02629120 | ACTIVE_NOT_RECRUITING | Chronic Granulomatous Disease Transplant |
National Institute of Allergy and Infectious Diseases (NIAID) |
2015-12-17 | PHASE1; PHASE2 |
| NCT07441967 | NOT_YET_RECRUITING | Hematologic Malignancies |
Institute of Hematology & Blood Diseases Hospital, China |
2026-02-20 | PHASE2 |
| NCT03619551 | ACTIVE_NOT_RECRUITING | SCID |
Center for International Blood and Marrow Transplant Research |
2018-10-22 | PHASE2 |
| NCT05735717 | RECRUITING | Hematologic Malignancy; Acute Leukemia; Remission; Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; AML; TP53; Intrachromosomal Amplification of Chromosome 21; Cytogenetic Abnormality; CNS Leukemia; Minimal Residual Disease; Myelodysplasia; Juvenile Myelomonocytic Leukemia; Somatic Mutation; PTPN11 Gene Mutation; N-RAS Gene Amplification; Neurofibromatosis 1; NF1 Mutation; CBL Gene Mutation; Monosomy 7; Chromosome Abnormality; Fetal Hemoglobin; Lymphoblastic Lymphoma; High Grade Non-Hodgkin's Lymphoma, Adult |
Masonic Cancer Center, University of Minnesota |
2023-05-11 | PHASE2 |
| NCT06879847 | RECRUITING | Relapsed or Refractory Acute Myeloid Leukemia |
The First Affiliated Hospital of Soochow University |
2024-12-01 | |
| NCT06959771 | RECRUITING | CD40L-HyperIgM Syndrome |
National Institute of Allergy and Infectious Diseases (NIAID) |
2025-07-16 | PHASE1; PHASE2 |
| NCT06252870 | RECRUITING | Graft Versus Host Disease; Hematologic Malignancy |
Nantes University Hospital |
2024-07-18 | PHASE2 |
| NCT06613035 | NOT_YET_RECRUITING | Acute Myeloid Leukemia |
Institute of Hematology & Blood Diseases Hospital, China |
2024-09-30 | PHASE3 |
| NCT07183878 | RECRUITING | Acute Myeloid Leukemia; High-Risk Acute Myeloid Leukemia; Myelodysplastic Syndromes; High-Risk Myelodysplastic Syndromes |
First Affiliated Hospital of Zhejiang University |
2025-08-20 | |
| NCT06079879 | ACTIVE_NOT_RECRUITING | Essential Thrombocythemia |
Merck Sharp & Dohme LLC |
2023-12-31 | PHASE3 |
| NCT01961063 | ACTIVE_NOT_RECRUITING | AIDS-related Non-Hodgkin Lymphoma; AIDS-related Plasmablastic Lymphoma; AIDS-related Primary Effusion Lymphoma; HIV Infection |
City of Hope Medical Center |
2015-12-31 | PHASE1 |
| NCT03597594 | ACTIVE_NOT_RECRUITING | Severe Combined Immunodeficiency |
St. Jude Children's Research Hospital |
2021-09-02 | PHASE1; PHASE2 |
| NCT02727803 | RECRUITING | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Acute Myeloid Leukemia With Variant MLL Translocations; B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1; Chemotherapy-Related Leukemia; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; ISS Stage II Plasma Cell Myeloma; ISS Stage III Plasma Cell Myeloma; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Myelodysplastic Syndrome With Gene Mutation; Myelodysplastic/Myeloproliferative Neoplasm; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Myeloid Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Adult Acute Lymphoblastic Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2016-05-19 | PHASE2 |
| NCT06996119 | RECRUITING | Acute Myeloid Leukemia; Graft Versus Host Disease; Myelodysplastic Syndrome |
City of Hope Medical Center |
2026-06-12 | PHASE1 |
| NCT04859946 | ACTIVE_NOT_RECRUITING | Hematologic and Lymphocytic Disorder |
M.D. Anderson Cancer Center |
2022-01-11 | PHASE2 |
| NCT04872595 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia (AML); Acute Lymphoid Leukemia (ALL); Myelodysplastic Syndromes (MDS) |
Memorial Sloan Kettering Cancer Center |
2021-04-30 | PHASE2 |
| NCT06548958 | RECRUITING | Malignant Hematological Diseases |
The First Affiliated Hospital of Soochow University |
2024-07-10 | |
| NCT06345495 | RECRUITING | Splenomegaly; Myelofibrosis |
M.D. Anderson Cancer Center |
2024-10-01 | PHASE2 |
| NCT03579875 | RECRUITING | Fanconi Anemia; Severe Aplastic Anemia; Myelodysplastic Syndromes; T Cell Receptor Alpha/Beta Depletion; Telomere Biology Disorder; Bone Marrow Failure; Dyskeratosis Congenita; Telomere Biology Disorders |
Masonic Cancer Center, University of Minnesota |
2018-11-13 | PHASE2 |
| NCT06385808 | NOT_YET_RECRUITING | Relapse Leukemia; Refractory Acute Myeloid Leukemia; Conditioning; Hematopoietic Stem Cell Transplantation |
First Affiliated Hospital Xi'an Jiaotong University |
2024-05-01 | |
| NCT07014943 | RECRUITING | Primary Central Nervous System Lymphoma (PCNSL) |
Sichuan University |
2022-01-01 | PHASE2 |
| NCT06001385 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Acute Leukemia; Myelodysplastic Syndromes; Chronic Myeloid Leukemia; Chronic Lymphocytic Leukemia; Myeloproliferative Neoplasm; Lymphoma; Chronic Myelomonocytic Leukemia; Pro-Lymphocytic Leukemia; Myelofibrosis |
Center for International Blood and Marrow Transplant Research |
2023-12-08 | PHASE2 |
| NCT04644016 | RECRUITING | AML; ALL; MDS; MPD Withou Myelofibrosis; NHL or HL; Inherited Metabolic Disorders; Hemoglobinopathies; Bone Marrow Failure; HLH |
Memorial Sloan Kettering Cancer Center |
2020-11-20 | PHASE2 |
| NCT05436561 | RECRUITING | Disease-free Survival |
Shanghai Jiao Tong University School of Medicine |
2022-06-01 | PHASE2 |
| NCT02143830 | RECRUITING | Fanconi Anemia; Severe Marrow Failure; Myelodysplastic Syndrome (MDS); Acute Myelogenous Leukemia (AML) |
Children's Hospital Medical Center, Cincinnati |
2014-04 | PHASE2 |
| NCT01176006 | ACTIVE_NOT_RECRUITING | DOCK8 Deficiency |
National Cancer Institute (NCI) |
2010-10-05 | PHASE2 |
| NCT06809712 | RECRUITING | Hematologic Disease |
He Huang |
2022-08-04 | PHASE1 |
| NCT06809699 | RECRUITING | Hematologic Diseases |
He Huang |
2022-08-04 | PHASE1 |
| NCT04098393 | ACTIVE_NOT_RECRUITING | Hematologic Malignancies |
Memorial Sloan Kettering Cancer Center |
2019-09-18 | PHASE1 |
| NCT06337331 | WITHDRAWN | Acute Myeloid Leukemia; Myelodysplastic Syndromes |
Northside Hospital, Inc. |
2024-08-31 | PHASE2 |
| NCT02500849 | ACTIVE_NOT_RECRUITING | HIV |
City of Hope Medical Center |
2016-03-10 | PHASE1 |
| NCT04904588 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Mixed Phenotype Acute Leukemia; Acute Leukemia; Myelodysplastic Syndromes; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Lymphoma |
Center for International Blood and Marrow Transplant Research |
2021-09-30 | PHASE2 |
| NCT01512888 | SUSPENDED | Severe Combined Immunodeficiency Disease, X-linked |
St. Jude Children's Research Hospital |
2016-08-17 | PHASE1; PHASE2 |
| NCT03601286 | UNKNOWN | Severe Combined Immunodeficiency, X-Linked |
Great Ormond Street Hospital for Children NHS Foundation Trust |
2018-12-21 | PHASE1 |
| NCT01985061 | ACTIVE_NOT_RECRUITING | Myelodysplastic Syndrome; Acute Myeloid Leukemia |
Institut Paoli-Calmettes |
2013-12 | PHASE2 |
| NCT06829472 | RECRUITING | Toxicities; Survivorship |
Shanghai Jiao Tong University School of Medicine |
2023-12-01 | PHASE3 |
| NCT02061800 | UNKNOWN | Chronic Myeloid Leukemia (CML); Acute Myelogenous Leukemia (AML); Myelodysplastic Syndrome (MDS); Juvenile Myelomonocytic Leukemia (JMML); Acute Lymphoblastic Leukemia (ALL); Lymphoma (Hodgkin's and Non-Hodgkin's) |
Diane George |
2013-06-03 | PHASE1; PHASE2 |
| NCT05457556 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Mixed Phenotype Acute Leukemia; Myelodysplastic Syndrome |
Children's Oncology Group |
2023-03-15 | PHASE3 |
| NCT03613532 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS); Chronic Myelomonocytic Leukemia (CMML); MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable); Hematopoietic Stem Cell Transplant |
Jacqueline Garcia, MD |
2018-10-24 | PHASE1 |
| NCT04384692 | ACTIVE_NOT_RECRUITING | Primary Myelofibrosis; Secondary Myelofibrosis |
Fred Hutchinson Cancer Center |
2020-12-18 | PHASE2 |
| NCT04547049 | ACTIVE_NOT_RECRUITING | Leukemia; MDS |
First Affiliated Hospital of Zhejiang University |
2020-09-01 | PHASE3 |
| NCT03121014 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia; Myelodysplastic Syndromes |
University of Illinois at Chicago |
2017-04-24 | PHASE2 |
| NCT05870995 | RECRUITING | Refractory Leukemia |
Shanghai Jiao Tong University School of Medicine |
2023-02-01 | PHASE2 |
| NCT05674539 | ENROLLING_BY_INVITATION | Acute Myeloid Leukemia, Adult; Myelodysplastic Syndrome(MDS); Allogeneic Hematopoietic Stem Cell Transplantation |
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology |
2023-02-15 | PHASE3 |
| NCT05466318 | UNKNOWN | Lymphoma, Large B-Cell, Diffuse; Lymphoma, T-Cell |
Sichuan University |
2022-07-01 | PHASE3 |
| NCT02859402 | RECRUITING | T-cell Non-Hodgkin Lymphoma; Lymphoma, Extranodal NK-T-Cell |
Keimyung University Dongsan Medical Center |
2016-12 | PHASE2 |
| NCT04370795 | WITHDRAWN | Severe Combined Immune Deficiency (SCID) |
National Institute of Allergy and Infectious Diseases (NIAID) |
2025-11-26 | PHASE1; PHASE2 |
| NCT06399107 | RECRUITING | Sickle Cell Disease; Sickle-Cell Disease With Crisis |
Essen Biotech |
2024-08-01 | PHASE1; PHASE2 |
| NCT03259503 | COMPLETED | Recurrent Diffuse Large B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Refractory Diffuse Large B-Cell Lymphoma; Refractory Hodgkin Lymphoma; Refractory T-Cell Non-Hodgkin Lymphoma |
M.D. Anderson Cancer Center |
2019-09-13 | PHASE1 |
| NCT05991908 | RECRUITING | Acute Myeloid Leukemia; Myelodysplastic Syndromes |
Shanghai Jiao Tong University School of Medicine |
2023-10-19 | PHASE3 |
| NCT05807659 | UNKNOWN | Myeloid Malignancies |
Sichuan University |
2023-03-16 | PHASE2 |
| NCT05907486 | UNKNOWN | Thrombotic Disorder |
The First Affiliated Hospital of Soochow University |
2023-08-01 | PHASE3 |
| NCT04945096 | UNKNOWN | Engraft Failure; Relapse; GVHD |
The First Affiliated Hospital of Soochow University |
2021-07-01 | PHASE3 |
| NCT04822532 | UNKNOWN | Hematopoietic Stem Cell Transplantation; Allogeneic Hematopoietic Stem Cell Transplantation; Autologous Hematopoietic Stem Cell Transplantation |
University Hospital, Geneva |
2021-06-15 | |
| NCT06125483 | RECRUITING | Hematopoietic Malignancy; Relapse/Recurrence; Hematopoietic Stem Cell Transplantation |
The First Affiliated Hospital of Soochow University |
2023-11-01 | |
| NCT01758328 | COMPLETED | Multiple Myeloma |
Memorial Sloan Kettering Cancer Center |
2012-12 | PHASE1 |
| NCT00408447 | UNKNOWN | Sickle Cell Disease; Beta Thalassemia |
Columbia University |
2004-09 | PHASE2 |
| NCT06069180 | UNKNOWN | Severe Aplastic Anemia |
Peking University People's Hospital |
2023-11-15 | PHASE4 |
| NCT06247917 | UNKNOWN | Myelodysplastic Syndrome With Excess Blasts-1; Myelodysplastic Syndrome With Excess Blasts-2; Myelodysplastic Syndromes |
Ruijin Hospital |
2024-03-03 | PHASE2 |
| NCT06625359 | TERMINATED | Central Nervous System Lymphoma |
Seoul National University Hospital |
2015-06-01 | PHASE2 |
| NCT05598593 | UNKNOWN | Cytarabine+Thiotepa + Fludarabine + Busulfan; T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma |
First Affiliated Hospital of Zhejiang University |
2022-10-23 | PHASE2 |
| NCT01701986 | COMPLETED | Hematopoietic Cell Transplantation Recipient; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Hodgkin Lymphoma; Refractory T-Cell Non-Hodgkin Lymphoma |
M.D. Anderson Cancer Center |
2012-10-25 | PHASE1; PHASE2 |
| NCT02506959 | COMPLETED | Plasma Cell Leukemia; Plasmacytoma; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma |
M.D. Anderson Cancer Center |
2015-09-14 | PHASE2 |
| NCT00357565 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Childhood Acute Myeloid Leukemia in Remission; Recurrent Childhood Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Childhood Acute Lymphoblastic Leukemia in Remission; Previously Treated Myelodysplastic Syndrome; Secondary Myelodysplastic Syndrome; Refractory Anemia With Excess Blasts in Transformation; Refractory Anemia With Excess Blasts; Refractory Anemia; De Novo Myelodysplastic Syndrome; Childhood Myelodysplastic Syndrome |
Masonic Cancer Center, University of Minnesota |
2005-11 | PHASE2 |
| NCT05579769 | TERMINATED | Hematologic Malignancy; Myeloid Malignancy |
St. Jude Children's Research Hospital |
2023-03-14 | PHASE2 |
| NCT04942730 | COMPLETED | Leukemia, Acute Lymphoblastic; Myeloid Leukemia, Acute; Biphenotypic Acute Leukemia; Lymphoblastic Lymphoma; Myelodysplastic Syndromes; Myeloproliferative Neoplasm |
St. Petersburg State Pavlov Medical University |
2021-01-21 | PHASE2 |
| NCT03615105 | TERMINATED | Acute Lymphoid Leukemia (ALL); Acute Myeloid Leukemia (AML); Chronic Myeloid Leukemia (CML); Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Chronic Lymphocytic Leukemia |
Memorial Sloan Kettering Cancer Center |
2018-07-25 | PHASE2 |
| NCT05170828 | WITHDRAWN | Acute Leukemia; Myelodysplastic Syndromes; T-lymphoblastic Lymphoma; Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; Acute Biphenotypic Leukemia; Acute Undifferentiated Leukemia |
Ossium Health, Inc. |
2022-09 | PHASE1 |
| NCT01505569 | COMPLETED | Ewing's Family Tumors; Renal Tumors; Hepatoblastoma; Rhabdomyosarcoma; Soft Tissue Sarcoma; Primary Malignant Brain Neoplasms; Retinoblastoma; Medulloblastoma; Supra-tentorial Primative Neuro-Ectodermal Tumor (PNET); Atypical Teratoid/Rhabdoid Tumor (AT/RT); CNS Tumors; Germ Cell Tumors |
Masonic Cancer Center, University of Minnesota |
2011-10-20 | |
| NCT04904237 | UNKNOWN | Refractory Acute Myeloid Leukemia |
Shanghai Jiao Tong University School of Medicine |
2021-01-01 | PHASE2 |
| NCT05449899 | UNKNOWN | Secondary Acute Myeloid Leukemia Evolving From MDS; Allogeneic Hematopoietic Stem Cell Transplantation; Conditioning |
Nanfang Hospital, Southern Medical University |
2022-07 | PHASE2; PHASE3 |
| NCT02034630 | UNKNOWN | Genetic Rare Disease |
Seoul National University Hospital |
2014-07-21 | PHASE1; PHASE2 |
| NCT05453552 | UNKNOWN | Myelodysplastic Syndrome; Allogeneic Hematopoietic Stem Cell Transplantation; Conditioning |
Nanfang Hospital, Southern Medical University |
2022-07-01 | PHASE2; PHASE3 |
| NCT02047578 | UNKNOWN | Acute Lymphoblastic Leukemia |
Seoul National University Hospital |
2014-02-05 | PHASE2 |
| NCT04451200 | NOT_YET_RECRUITING | Acute Leukemia; Mielodysplasic Syndrome; Myeloproliferative Neoplasm |
Institut Paoli-Calmettes |
2020-11 | PHASE2 |
| NCT03240861 | TERMINATED | HLA-A*0201 Positive Cells Present; Locally Advanced Malignant Neoplasm; NY-ESO-1 Positive; Unresectable Malignant Neoplasm; Sarcoma |
Jonsson Comprehensive Cancer Center |
2017-07-26 | PHASE1 |
| NCT02512497 | COMPLETED | Cutaneous T-cell Lymphoma; T-Prolymphocytic Leukemia; T-Large Granulocytic Leukemia; T-Lymphoblastic Leukemia/Lymphoma; Peripheral T-Cell Lymphoma |
Ohio State University Comprehensive Cancer Center |
2017-12-08 | PHASE1 |
| NCT05569512 | TERMINATED | Acute Myeloid Leukemia; Pediatric Cancer |
Malika Kapadia |
2022-10-06 | PHASE1 |
| NCT05293509 | WITHDRAWN | Stem Cell Transplantation |
M.D. Anderson Cancer Center |
2022-03-02 | PHASE2 |
| NCT03602898 | WITHDRAWN | Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Hematopoietic and Lymphoid System Neoplasm; Myelodysplastic Syndrome; Myelofibrosis; Myeloproliferative Neoplasm; Recurrent Acute Myeloid Leukemia; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Refractory Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia |
Fred Hutchinson Cancer Center |
2021-06-01 | PHASE2 |
| NCT04151706 | COMPLETED | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndromes; Acute Leukemia; Chronic Myeloid Leukemia |
Robert Lowsky |
2020-02-27 | PHASE2 |
| NCT04713956 | UNKNOWN | Myelodysplastic Syndrome; Allogeneic Hematopoietic Stem Cell Transplantation; Conditioning |
Nanfang Hospital, Southern Medical University |
2021-01-15 | PHASE2; PHASE3 |
| NCT03852498 | COMPLETED | Cerebral Adrenoleukodystrophy (CALD) |
Genetix Biotherapeutics Inc. |
2019-01-24 | PHASE3 |
| NCT02766465 | COMPLETED | Sickle Cell Disease |
Medical College of Wisconsin |
2017-03-16 | PHASE2 |
| NCT05425654 | UNKNOWN | Primary CNS Lymphoma |
National Research Center for Hematology, Russia |
2021-05-17 | PHASE2 |
| NCT02221310 | COMPLETED | Acute Myelogenous Leukemia; Myelodysplastic Syndrome |
New York Medical College |
2011-12-07 | PHASE2 |
| NCT00596154 | COMPLETED | CNS Lymphoma; CNS Brain Cancer; Non-Hodgkin's Lymphoma |
Memorial Sloan Kettering Cancer Center |
2004-12 | PHASE2 |
| NCT00588523 | COMPLETED | CNS Cancer; CNS BRAIN |
Memorial Sloan Kettering Cancer Center |
2002-09 | PHASE2 |
| NCT00534469 | COMPLETED | Leukemia |
City of Hope Medical Center |
2000-02-08 | PHASE2 |
| NCT02251821 | COMPLETED | Primary Myelofibrosis; Secondary Myelofibrosis |
Fred Hutchinson Cancer Center |
2014-10-20 | PHASE2 |
| NCT04776850 | WITHDRAWN | Beta Thalassemia Major; Sickle Beta 0 Thalassemia; Sickle Beta Plus Thalassemia; Sickle Beta Thalassemia; Sickle Cell Disease; Sickle Cell-SS Disease |
M.D. Anderson Cancer Center |
2020-12-29 | EARLY_PHASE1 |
| NCT03315078 | UNKNOWN | X-Linked Combined Immunodeficiency Diseases |
National Institute of Allergy and Infectious Diseases (NIAID) |
2012-04 | PHASE1; PHASE2 |
| NCT02582775 | COMPLETED | Epidermolysis Bullosa |
Masonic Cancer Center, University of Minnesota |
2016-03 | PHASE2 |
| NCT03795597 | UNKNOWN | Multiple Myeloma |
Loyola University |
2019-05-22 | PHASE1; PHASE2 |
| NCT01349101 | COMPLETED | Hematological Malignancies |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2011-02-10 | PHASE2 |
| NCT03096782 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Biphenotypic Leukemia; Acute Leukemia; Acute Lymphoblastic Leukemia; Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Chemotherapy-Related Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Hodgkin Lymphoma; Langerhans Cell Histiocytosis; Minimal Residual Disease; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Non-Hodgkin Lymphoma; Recurrent Hodgkin Lymphoma; Refractory Acute Lymphoblastic Leukemia; Refractory Myelodysplastic Syndrome; Small Lymphocytic Lymphoma; Therapy-Related Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2017-10-13 | PHASE2 |
| NCT04123392 | UNKNOWN | TP53; Myeloid Tumors; Conditioning; Allogeneic Hematopoietic Stem Cell Transplantation |
Nanfang Hospital, Southern Medical University |
2019-10 | PHASE2; PHASE3 |
| NCT04002115 | TERMINATED | Acute Myeloid Leukemia |
Milton S. Hershey Medical Center |
2020-06-03 | PHASE2 |
| NCT01572662 | COMPLETED | Leukemia; Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Chronic Myeloid Leukemia; Chronic Lymphocytic Leukemia; Myeloproliferative Diseases; Non-Hodgkins Lymphoma; Hodgkins Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2012-04-11 | PHASE2 |
| NCT04098653 | UNKNOWN | Allogeneic Hematopoietic Stem Cell Transplantation; Conditioning; Myeloid Tumors |
Nanfang Hospital, Southern Medical University |
2019-09 | PHASE2; PHASE3 |
| NCT03384225 | UNKNOWN | High Risk Acute Myeloid Leukemia; Allogeneic Hematopoeitic Stem Cell Transplantation |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2016-08-01 | PHASE3 |
| NCT00630565 | TERMINATED | Leukemia |
Masonic Cancer Center, University of Minnesota |
2006-07-26 | PHASE2; PHASE3 |
| NCT01823198 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Acute Erythroid Leukemia; Acute Megakaryoblastic Leukemia; Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Acute Myeloid Leukemia in Remission; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Blasts Under 20 Percent of Bone Marrow Nucleated Cells; Blasts Under 20 Percent of Peripheral Blood White Cells; Chronic Myelomonocytic Leukemia; High Risk Myelodysplastic Syndrome; Myelodysplastic Syndrome; Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Therapy-Related Acute Myeloid Leukemia; Therapy-Related Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2013-06-11 | PHASE1; PHASE2 |
| NCT03515707 | WITHDRAWN | Acute Myeloid Leukemia; Minimal Residual Disease Negativity |
Fred Hutchinson Cancer Center |
2018-07-10 | PHASE2 |
| NCT01760655 | COMPLETED | Acute Myeloid Leukemia With FLT3/ITD Mutation; Acute Myeloid Leukemia With Gene Mutations; Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM; Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214; Aplastic Anemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Follicular Lymphoma; Hodgkin Lymphoma; Myelodysplastic Syndrome; Myelofibrosis; Myeloid Leukemia; Non-Hodgkin Lymphoma; Plasma Cell Myeloma; Polycythemia Vera; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Refractory Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Therapy-Related Acute Myeloid Leukemia |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2012-12-24 | PHASE2 |
| NCT03513328 | COMPLETED | Bone Marrow Failure Syndrome; Thalassemia; Sickle Cell Disease; Diamond Blackfan Anemia; Acquired Neutropenia in Newborn; Acquired Anemia Hemolytic; Acquired Thrombocytopenia; Hemophagocytic Lymphohistiocytoses; Wiskott-Aldrich Syndrome; Chronic Granulomatous Disease; Common Variable Immunodeficiency; X-linked Lymphoproliferative Disease; Severe Combined Immunodeficiency; Hurler Syndrome; Mannosidosis; Adrenoleukodystrophy |
University of Florida |
2018-06-15 | PHASE1; PHASE2 |
| NCT02248597 | COMPLETED | Graft Versus Host Disease; Hematopoietic/Lymphoid Cancer |
Wake Forest University Health Sciences |
2015-02-25 | PHASE2 |
| NCT01498016 | UNKNOWN | Acute Leukemia |
Shanghai Jiao Tong University School of Medicine |
2011-11 | PHASE2 |
| NCT03171831 | UNKNOWN | Thalassemia Major |
First Affiliated Hospital of Guangxi Medical University |
2017-04-01 | PHASE4 |
| NCT02083250 | COMPLETED | Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia in Remission; Allogeneic Hematopoietic Stem Cell Transplantation Recipient; Myelodysplastic Syndrome; Previously Treated Myelodysplastic Syndrome; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia |
M.D. Anderson Cancer Center |
2014-03-06 | PHASE1 |
| NCT04220008 | WITHDRAWN | Recurrent Aggressive Non-Hodgkin Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Burkitt Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent High Grade B-Cell Lymphoma; Recurrent T-Cell Non-Hodgkin Lymphoma; Recurrent Transformed B-Cell Non-Hodgkin Lymphoma |
M.D. Anderson Cancer Center |
2021-10-29 | PHASE2 |
| NCT03733327 | UNKNOWN | Primary Central Nervous System Lymphoma; Autologous Hematopoietic Stem Cell Transplantation; Conditioning |
Nanfang Hospital, Southern Medical University |
2018-11 | PHASE2; PHASE3 |
| NCT01704716 | RECRUITING | Neuroblastoma |
St. Anna Kinderkrebsforschung |
2002-02 | PHASE3 |
| NCT03765632 | COMPLETED | Severe Combined Immunodeficiency Due to ADA Deficiency |
Great Ormond Street Hospital for Children NHS Foundation Trust |
2018-01-03 | PHASE1; PHASE2 |
| NCT01019876 | COMPLETED | Bone Marrow Failure; Osteopetrosis; Fanconi Anemia; Severe Combined Immunodeficiency |
Columbia University |
2002-09 | PHASE2; PHASE3 |
| NCT02544425 | UNKNOWN | Extranodal NK-T-Cell Lymphoma |
Samsung Medical Center |
2016-02-21 | PHASE2 |
| NCT01033552 | COMPLETED | Epidermolysis Bullosa |
Masonic Cancer Center, University of Minnesota |
2010-01 | PHASE1; PHASE2 |
| NCT03596892 | UNKNOWN | Allogeneic Hematopoietic Stem Cell Transplantation; Conditions; Mixed-lineage-leukemia (MLL)-Rearranged Acute Leukemia |
Nanfang Hospital, Southern Medical University |
2018-07 | PHASE2; PHASE3 |
| NCT02961816 | WITHDRAWN | Lymphoma |
M.D. Anderson Cancer Center |
2017-06 | PHASE2 |
| NCT03600909 | TERMINATED | Fanconi Anemia; Myelodysplastic Syndrome (MDS); Acute Myelogenous Leukemia (AML) |
Memorial Sloan Kettering Cancer Center |
2018-05-15 | PHASE2 |
| NCT02670564 | UNKNOWN | Acute Lymphoblastic Leukemia |
Swiss Pediatric Oncology Group |
2013-04 | PHASE4 |
| NCT01119066 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Multiple Myeloma |
Memorial Sloan Kettering Cancer Center |
2010-05-03 | PHASE2 |
| NCT03602131 | UNKNOWN | Hodgkin Lymphoma; Non-hodgkin Lymphoma |
Sichuan University |
2019-01-01 | PHASE2 |
| NCT03517631 | UNKNOWN | HIV Infections; AIDS |
Shanghai Public Health Clinical Center |
2018-02-27 | PHASE1 |
| NCT01471444 | COMPLETED | Disorder Related to Bone Marrow Transplantation; Leukemia; Transplantation Infection |
M.D. Anderson Cancer Center |
2011-11-02 | PHASE3 |
| NCT01773395 | TERMINATED | Myelodysplastic Syndrome; Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia |
Dana-Farber Cancer Institute |
2013-01-08 | PHASE2 |
| NCT03385096 | UNKNOWN | Autologous Hematopoietic Stem Cell Transplantation; Conditioning; Multiple Myeloma |
Nanfang Hospital, Southern Medical University |
2018-01-02 | PHASE2; PHASE3 |
| NCT03151876 | UNKNOWN | Lymphoma |
Sichuan University |
2017-06-12 | PHASE2 |
| NCT02605460 | UNKNOWN | Acute Myeloid Leukemia; Acute Lymphoid Leukemia |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2014-02 | PHASE2 |
| NCT04451200 | Not yet recruiting | Acute Leukemia|Mielodysplasic Syndrome|Myeloproliferative Neoplasm |
Institut Paoli-Calmettes |
2020-11 | Phase 2 |
| NCT02799147 | COMPLETED | Leukemia, Acute Lymphoblastic; Acute Myeloid Leukemia; Mixed-Lineage Acute Leukemias |
St. Petersburg State Pavlov Medical University |
2016-06 | PHASE1; PHASE2 |
| NCT02670109 | UNKNOWN | Triple-Negative Invasive Breast Carcinoma; Residual Tumor |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2018-02-01 | PHASE2 |
| NCT00629798 | COMPLETED | Acute Myeloid Leukemia; Advanced Myelodysplastic Syndromes |
Memorial Sloan Kettering Cancer Center |
2008-02-12 | PHASE2 |
| NCT00258427 | COMPLETED | Fanconi Anemia |
Masonic Cancer Center, University of Minnesota |
2002-03-26 | PHASE2 |
| NCT02441803 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
2015-09-14 | PHASE2 |
| NCT04127721 | WITHDRAWN | Allogeneic Stem Cell Transplant Recipient; Hematologic and Lymphocytic Disorder; Hematopoietic and Lymphoid Cell Neoplasm |
M.D. Anderson Cancer Center |
2020-09-22 | PHASE2 |
| NCT03339700 | UNKNOWN | Acute Lymphoblastic Leukemia, Adult |
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran |
2018-09-15 | PHASE2 |
| NCT01366612 | TERMINATED | Myeloid Malignancies; Acute Myelogenous Leukemia; Chronic Myelogenous Leukemia; Myeloproliferative Disorders; Myelodysplastic Syndrome |
Hackensack Meridian Health |
2010-06-16 | PHASE3 |
| NCT03128359 | COMPLETED | Acute Leukemia; Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Diffuse Large B-Cell Lymphoma; Follicular Lymphoma; Graft Versus Host Disease; Hodgkin Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma; Secondary Myelodysplastic Syndrome |
City of Hope Medical Center |
2017-05-30 | PHASE2 |
| NCT00950846 | COMPLETED | Congenital Pediatric Disorders |
Baylor College of Medicine |
2009-09 | |
| NCT03674411 | ACTIVE_NOT_RECRUITING | Acute Myeloid Leukemia; Acute Lymphocytic Leukemia; Biphenotypic/Undifferentiated Leukemia; Chronic Myelogenous Leukemia; Myelodysplasia; Relapsed Large Cell Lymphoma; Mantle Cell Lymphoma; Hodgkin Lymphoma; Burkitt Lymphoma; Relapsed T-Cell Lymphoma; Lymphoplasmacytic Lymphoma |
Masonic Cancer Center, University of Minnesota |
2019-01-02 | PHASE2 |
| NCT03229616 | UNKNOWN | Autologous Hematopoietic Stem Cell Transplantation; Diffuse Large B-cell Lymphoma; Conditioning |
Nanfang Hospital, Southern Medical University |
2017-07-05 | PHASE2; PHASE3 |
| NCT01131169 | COMPLETED | Multiple Myeloma |
Memorial Sloan Kettering Cancer Center |
2010-05 | PHASE2 |
| NCT02349906 | COMPLETED | Primary Immunodeficiencies; Inborn Errors of Metabolism; Haemoglobinopathies; Bone Marrow Failure Syndromes |
medac GmbH |
2015-04 | PHASE2 |
| NCT03235973 | UNKNOWN | Leukemia, Myeloid, Acute; Leukemia, Lymphoblastic, Acute |
Institut Paoli-Calmettes |
2018-04-28 | PHASE1 |
| NCT02793544 | COMPLETED | Myelodysplastic Syndrome (MDS); Chronic Lymphocytic Leukemia (CLL); Chemotherapy-sensitive Lymphoma; Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma; Acute Myelogenous Leukemia (AML); Acute Biphenotypic Leukemia (ABL); Acute Undifferentiated Leukemia (AUL) |
Center for International Blood and Marrow Transplant Research |
2016-12 | PHASE2 |
| NCT01685411 | TERMINATED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Myelodysplastic Syndrome |
Masonic Cancer Center, University of Minnesota |
2013-01 | |
| NCT01625351 | COMPLETED | Ewing Sarcoma; Gastrointestinal Tumor; Germ Cell Tumor; Hepatic Tumor; Lymphoma; Wilms Tumor; Rhabdoid Tumor; Clear Cell Carcinoma; Renal Cell Carcinoma; Melanoma; Neuroblastoma; Rhabdomyosarcoma; Non-rhabdomyosarcoma |
St. Jude Children's Research Hospital |
2012-08-20 | PHASE1 |
| NCT01380990 | COMPLETED | Adenosine Deaminase Deficiency; Severe Combined Immunodeficiencies (SCID) |
Great Ormond Street Hospital for Children NHS Foundation Trust |
2012-11-15 | PHASE1; PHASE2 |
| NCT02836639 | UNKNOWN | Lymphoma, Non-Hodgkin |
Pusan National University Hospital |
2016-02 | PHASE2 |
| NCT00176930 | TERMINATED | Leukemia, Myeloid, Chronic; AML; Leukemia, Lymphocytic, Acute; MDS; Leukemia, Lymphocytic, Chronic; JMML; Hodgkin's Disease; Non-hodgkin's Lymphoma; Multiple Myeloma |
Masonic Cancer Center, University of Minnesota |
2001-10 | |
| NCT00612716 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm |
Masonic Cancer Center, University of Minnesota |
1999-10-06 | PHASE2 |
| NCT00426517 | COMPLETED | Inherited Immune Deficiencies |
National Institute of Allergy and Infectious Diseases (NIAID) |
2007-01-19 | EARLY_PHASE1 |
| NCT01247701 | COMPLETED | Myeloid Hematological Malignancies |
Baylor College of Medicine |
2010-11 | |
| NCT02744742 | COMPLETED | Myelodysplastic Syndrome; Allogeneic Hematopoietic Stem Cell Transplantation; Conditioning |
Nanfang Hospital, Southern Medical University |
2016-04-18 | PHASE2; PHASE3 |
| NCT02784561 | UNKNOWN | Leukemia |
Chinese PLA General Hospital |
2016-07 | PHASE4 |
| NCT02916979 | COMPLETED | Leukemia, Lymphoid; Leukemia, Myeloid; Myelodysplastic Syndromes; Myelofibrosis; Lymphoma, Malignant; Multiple Myeloma; Waldenstrom Macroglobulinemia |
Dartmouth-Hitchcock Medical Center |
2016-09-06 | PHASE1 |
| NCT01596699 | TERMINATED | Myeloid Malignancy; Bone Marrow Failure Syndrome; Transfusion-dependent Red Blood Cell (RBC) Defect; Congenital Immunodeficiency; Metabolic Disease; Severe Immune Dysregulation |
University of California, San Francisco |
2012-05-24 | PHASE2 |
| NCT02701673 | WITHDRAWN | Lymphoma |
M.D. Anderson Cancer Center |
2016-06 | PHASE1; PHASE2 |
| NCT03303950 | TERMINATED | Anemia; ASXL1 Gene Mutation; EZH2 Gene Mutation; IDH1 Gene Mutation; IDH2 Gene Mutation; Plasma Cell Myeloma; Primary Myelofibrosis; Recurrent Plasma Cell Myeloma; Secondary Myelofibrosis; Thrombocytopenia |
University of Utah |
2018-03-30 | PHASE2 |
| NCT02282904 | TERMINATED | Chronic Granulomatous Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
2014-10-23 | PHASE1; PHASE2 |
| NCT02589145 | TERMINATED | Lymphoma |
M.D. Anderson Cancer Center |
2016-06-22 | PHASE1; PHASE2 |
| NCT02627573 | TERMINATED | Leukemia, Chronic Myeloid; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative |
St. Petersburg State Pavlov Medical University |
2015-07 | PHASE2 |
| NCT01413178 | COMPLETED | Myeloma |
M.D. Anderson Cancer Center |
2011-09-30 | PHASE3 |
| NCT00857389 | COMPLETED | Stem Cell Transplantation; Leukemia; Lymphoma |
M.D. Anderson Cancer Center |
2009-03-02 | PHASE2 |
| NCT02671708 | COMPLETED | Autologous Hematopoietic Stem Cell Transplantation; Acute Myeloid Leukemia; Conditioning |
Nanfang Hospital, Southern Medical University |
2016-01 | PHASE2; PHASE3 |
| NCT03018223 | COMPLETED | Non-Hodgkin's Lymphoma; Acute Leukemia in Remission; Chronic Myeloid Leukemia; Primary Myelofibrosis; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes; Hodgkin Lymphoma; Multiple Myeloma |
H. Lee Moffitt Cancer Center and Research Institute |
2017-01-31 | PHASE1 |
| NCT01200329 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
2011-06 | PHASE2 |
| NCT03601286 | Recruiting | Severe Combined Immunodeficiency X-Linked |
Great Ormond Street Hospital for Children NHS Foundation Trust |
2018-12-21 | Phase 1 |
| NCT02999984 | COMPLETED | Severe Combined Immunodeficiency Due to ADA Deficiency |
University of California, Los Angeles |
2016-12-16 | PHASE1; PHASE2 |
| NCT02114502 | WITHDRAWN | Myeloma |
M.D. Anderson Cancer Center |
2014-09 | PHASE2 |
| NCT00943800 | COMPLETED | Leukemia; Myelodysplastic Syndrome; Multiple Myeloma; Lymphoma |
University of Chicago |
2006-10-09 | |
| NCT01852071 | COMPLETED | ADA-SCID |
University of California, Los Angeles |
2013-08-02 | PHASE1; PHASE2 |
| NCT00536601 | COMPLETED | Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor (PNET); Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-cell Lymphoma; Plasma Cell Neoplasm; Primary Systemic Amyloidosis; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Malignant Testicular Germ Cell Tumor; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Neuroblastoma; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Multiple Myeloma; Regional Neuroblastoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific; Waldenström Macroglobulinemia |
Roswell Park Cancer Institute |
2006-06-29 | |
| NCT01435447 | COMPLETED | Lymphoid Malignancies |
Shanghai Jiao Tong University School of Medicine |
2011-04 | PHASE2 |
| NCT02120157 | COMPLETED | Myeloablative Conditioning; HLA-mismatched Bone Marrow Transplantation; Graft Survival; Transplantation, Bone Marrow |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2015-07-02 | PHASE2 |
| NCT02333838 | UNKNOWN | Leukemia, Myeloid |
Assistance Publique - Hôpitaux de Paris |
2015-05 | PHASE2 |
| NCT01629511 | TERMINATED | Allogeneic Hematopoietic Stem Cell Transplantation Recipient; Chronic Lymphocytic Leukemia; Prolymphocytic Leukemia; Richter Syndrome |
M.D. Anderson Cancer Center |
2012-11-21 | PHASE1; PHASE2 |
| NCT03235973 | Unknown status | Leukemia Myeloid Acute|Leukemia Lymphoblastic Acute |
Institut Paoli-Calmettes |
2018-04-28 | Phase 1 |
| NCT02483325 | COMPLETED | Hematological Diseases |
Institut Paoli-Calmettes |
2014-09 | PHASE2 |
| NCT01605032 | COMPLETED | DS Stage I Plasma Cell Myeloma; DS Stage II Plasma Cell Myeloma; DS Stage III Plasma Cell Myeloma; Refractory Plasma Cell Myeloma |
Albert Einstein College of Medicine |
2012-02 | PHASE2 |
| NCT01795430 | WITHDRAWN | Adult Supratentorial Primitive Neuroectodermal Tumor (PNET); Ewing Sarcoma of Bone; Extraosseous Ewing Sarcoma; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor; Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor |
City of Hope Medical Center |
2013-07 | |
| NCT00822393 | COMPLETED | Acute Myeloid Leukemia; Myelodysplastic Syndrome |
medac GmbH |
2008-11-24 | PHASE3 |
| NCT02057770 | TERMINATED | Leukemia, Myeloid, Acute |
Washington University School of Medicine |
2014-02-28 | PHASE1 |
| NCT00004088 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
City of Hope Medical Center |
1999-04-13 | PHASE2 |
| NCT01779882 | COMPLETED | Myeloid Leukemia; Precursor Myeloid Neoplasms; Lymphoid Neoplasms |
University Hospital, Basel, Switzerland |
2013-01 | |
| NCT01824693 | COMPLETED | Juvenile Myelomonocytic Leukemia |
Children's Oncology Group |
2013-06-24 | PHASE2 |
| NCT02130869 | COMPLETED | Neuroblastoma; Lymphoma; High-risk Tumor |
St. Jude Children's Research Hospital |
2014-10-10 | PHASE1 |
| NCT01338987 | COMPLETED | Myelodysplastic Syndrome; Acute Lymphocytic Leukemia; Acute Myelogenous Leukemia; Chronic Myelogenous Leukemia; Chronic Myelomonocytic Leukemia |
National Cancer Institute (NCI) |
2011-04-19 | PHASE2 |
| NCT00943319 | COMPLETED | Leukemia; Lymphoma; Myeloma |
University of Chicago |
2012-03 | PHASE1; PHASE2 |
| NCT01983969 | COMPLETED | Advanced Cancers; Lymphoma |
M.D. Anderson Cancer Center |
2013-11-07 | PHASE1; PHASE2 |
| NCT01572181 | COMPLETED | Hematologic Malignancy |
Nantes University Hospital |
2012-04 | PHASE2 |
| NCT00003270 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Roswell Park Cancer Institute |
1997-09-04 | PHASE2 |
| NCT00475020 | COMPLETED | Myelofibrosis |
M.D. Anderson Cancer Center |
2006-01-04 | PHASE2 |
| NCT01237951 | COMPLETED | Myeloma |
M.D. Anderson Cancer Center |
2010-11-08 | PHASE2 |
| NCT01734850 | COMPLETED | Human Immunodeficiency Virus |
Calimmune, Inc. |
2013-04 | PHASE1; PHASE2 |
| NCT01707004 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); de Novo Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia |
University of Wisconsin, Madison |
2013-05-16 | PHASE2 |
| NCT00987480 | COMPLETED | Aplastic Anemia; Leukemia; Myelodysplastic Syndrome |
Memorial Sloan Kettering Cancer Center |
2009-09-25 | PHASE2 |
| NCT03794167 | COMPLETED | Non-hodgkin Lymphoma |
Soonchunhyang University Hospital |
2012-06-01 | PHASE2 |
| NCT02750254 | TERMINATED | Acute Myeloid Leukemia; Myelodysplastic Syndrome; Acute Lymphocytic Leukemia |
Washington University School of Medicine |
2016-06-27 | PHASE1 |
| NCT01471067 | COMPLETED | Blood And Marrow Transplantation; Leukemia; Lymphoma; Transplantation Infection; Transplantation, Bone Marrow |
M.D. Anderson Cancer Center |
2012-07-13 | PHASE1 |
| NCT02410551 | TERMINATED | Myeloproliferative Diseases |
M.D. Anderson Cancer Center |
2015-06-15 | PHASE2 |
| NCT02577094 | WITHDRAWN | Lymphocyte B CD22 Positive Acute Lymphoblastic Leukemia |
Nantes University Hospital |
PHASE1; PHASE2 | |
| NCT01814475 | COMPLETED | Myelofibrosis |
Gruppo Italiano Trapianto di Midollo Osseo |
2011-07 | PHASE2 |
| NCT02354443 | TERMINATED | Metabolic Disorders |
Fate Therapeutics |
2015-06 | PHASE1 |
| NCT02294552 | COMPLETED | Acute Myeloid Leukemia; Acute Lymphoid Leukemia; Lymphoma; Myelodysplastic Syndromes; Chronic Lymphocytic Leukemia; Immune System Diseases |
Ivan S Moiseev |
2014-10 | PHASE2 |
| NCT01410344 | COMPLETED | Leukemia; Lymphoma; HIV |
Medical College of Wisconsin |
2011-09 | PHASE2 |
| NCT00498316 | COMPLETED | Myelodysplastic Syndrome; Leukemia |
M.D. Anderson Cancer Center |
2007-07-03 | PHASE1 |
| NCT01969942 | WITHDRAWN | Ewing Sarcoma |
University of Louisville |
2013-04 | PHASE1 |
| NCT01175356 | COMPLETED | Ganglioneuroblastoma; Localized Resectable Neuroblastoma; Localized Unresectable Neuroblastoma; Regional Neuroblastoma; Stage 4 Neuroblastoma; Stage 4S Neuroblastoma |
Children's Oncology Group |
2011-12-21 | PHASE1 |
| NCT01071239 | COMPLETED | Fanconi Anemia |
Medical College of Wisconsin |
2009-04 | PHASE2 |
| NCT02469974 | WITHDRAWN | Myelofibrosis; MF |
Marina Kremyanskaya |
2015-05 | |
| NCT01643668 | COMPLETED | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome |
Massachusetts General Hospital |
2012-07 | PHASE2 |
| NCT00553202 | COMPLETED | Leukemia |
Children's Oncology Group |
2008-01 | PHASE2 |
| NCT00990249 | COMPLETED | Leukemia; Lymphoma; Allogeneic Haematopoietic Stem Cell Transplantation; Acute Lymphoblastic Leukemia |
M.D. Anderson Cancer Center |
2009-10 | PHASE2 |
| NCT00578292 | TERMINATED | Thalassemia |
Baylor College of Medicine |
2004-02 | |
| NCT00988013 | COMPLETED | Acute Myeloid Leukemia; Lymphoblastic Leukemia; Acute Leukemia; Non Hodgkins Lymphoma; Chronic Myeloid Leukemia |
University of Illinois at Chicago |
2009-09 | |
| NCT01027000 | COMPLETED | Leukemia; Lymphoma |
Alliance for Clinical Trials in Oncology |
2010-02 | PHASE2 |
| NCT01766375 | UNKNOWN | Acute Myeloid Leukemia |
Guangxi Medical University |
2012-08 | PHASE3 |
| NCT01621477 | TERMINATED | Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia; Chronic Myelocytic Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome; Hodgkin or Non-Hodgkin Lymphoma; Sarcoma, Myeloid |
St. Jude Children's Research Hospital |
2012-08 | PHASE2 |
| NCT01093586 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Erythroleukemia (M6a); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Adult Pure Erythroid Leukemia (M6b); B-cell Adult Acute Lymphoblastic Leukemia; B-cell Childhood Acute Lymphoblastic Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Erythroleukemia (M6); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Minimally Differentiated Myeloid Leukemia (M0); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Juvenile Myelomonocytic Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Previously Treated Myelodysplastic Syndromes; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Secondary Myelofibrosis; Splenic Marginal Zone Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia; T-cell Adult Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia; T-cell Large Granular Lymphocyte Leukemia; Waldenstrom Macroglobulinemia |
Case Comprehensive Cancer Center |
2007-09 | PHASE2 |
| NCT01168219 | COMPLETED | Acute Myeloid Leukemia; Adult Acute Megakaryoblastic Leukemia; Adult Acute Monoblastic Leukemia; Adult Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With Maturation; Adult Acute Myeloid Leukemia With Minimal Differentiation; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1; Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL; Adult Acute Myeloid Leukemia Without Maturation; Adult Acute Myelomonocytic Leukemia; Adult Erythroleukemia; Adult Pure Erythroid Leukemia; Alkylating Agent-Related Acute Myeloid Leukemia; de Novo Myelodysplastic Syndrome; Myelodysplastic Syndrome; Myelodysplastic Syndrome With Excess Blasts; Recurrent Adult Acute Myeloid Leukemia; Secondary Myelodysplastic Syndrome |
National Cancer Institute (NCI) |
2010-07-15 | PHASE2 |
| NCT00448357 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
UNC Lineberger Comprehensive Cancer Center |
2005-10 | PHASE1; PHASE2 |
| NCT00881556 | TERMINATED | Epidermolysis Bullosa |
Columbia University |
2009-08-20 | EARLY_PHASE1 |
| NCT01421173 | COMPLETED | Lymphoma |
M.D. Anderson Cancer Center |
2011-08 | PHASE1 |
| NCT00238433 | COMPLETED | Lymphoma |
OHSU Knight Cancer Institute |
2005-03 | PHASE2 |
| NCT00245037 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition |
OHSU Knight Cancer Institute |
2005-06 | PHASE1; PHASE2 |
| NCT01798004 | COMPLETED | Ganglioneuroblastoma; Stage 1 Neuroblastoma; Stage 2 Neuroblastoma; Stage 2A Neuroblastoma; Stage 2B Neuroblastoma; Stage 3 Neuroblastoma; Stage 4 Neuroblastoma; Stage 4S Neuroblastoma |
Children's Oncology Group |
2013-04-09 | PHASE1 |
| NCT01020734 | COMPLETED | Leukemia |
Asan Medical Center |
2011-05 | PHASE2 |
| NCT00800839 | COMPLETED | Hematologic Diseases; Leukemia; Lymphoma; Myeloma |
M.D. Anderson Cancer Center |
2008-09 | PHASE2 |
| NCT00003875 | COMPLETED | Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Childhood Acute Myeloid Leukemia in Remission; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia |
Fred Hutchinson Cancer Center |
1998-10-13 | PHASE2 |
| NCT01043640 | COMPLETED | Mucopolysaccharidosis; Hurler Syndrome; Hunter Syndrome; Maroteaux-Lamy Syndrome; Sly Syndrome; Alpha Mannosidosis; Fucosidosis; Aspartylglucosaminuria; Adrenoleukodystrophy (ALD); Krabbe Disease; Metachromatic Leukodystrophy (MLD); Sphingolipidoses; Peroxisomal Disorders |
Masonic Cancer Center, University of Minnesota |
2009-12 | PHASE2 |
| NCT00679536 | UNKNOWN | Leukemia |
Ann & Robert H Lurie Children's Hospital of Chicago |
2008-05 | PHASE1; PHASE2 |
| NCT01279616 | TERMINATED | Sickle Cell Disease |
Nationwide Children's Hospital |
2010-09 | PHASE2 |
| NCT01959477 | COMPLETED | Adult Grade III Lymphomatoid Granulomatosis; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Childhood Burkitt Lymphoma; Childhood Diffuse Large Cell Lymphoma; Childhood Grade III Lymphomatoid Granulomatosis; Childhood Immunoblastic Large Cell Lymphoma; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Refractory Hairy Cell Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Hodgkin Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Childhood Anaplastic Large Cell Lymphoma; Stage I Childhood Hodgkin Lymphoma; Stage I Childhood Large Cell Lymphoma; Stage I Childhood Lymphoblastic Lymphoma; Stage I Childhood Small Noncleaved Cell Lymphoma; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Small Lymphocytic Lymphoma; Stage IA Mycosis Fungoides/Sezary Syndrome; Stage IB Mycosis Fungoides/Sezary Syndrome; Stage II Adult Hodgkin Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Childhood Anaplastic Large Cell Lymphoma; Stage II Childhood Hodgkin Lymphoma; Stage II Childhood Large Cell Lymphoma; Stage II Childhood Lymphoblastic Lymphoma; Stage II Childhood Small Noncleaved Cell Lymphoma; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IIA Mycosis Fungoides/Sezary Syndrome; Stage IIB Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Hodgkin Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Childhood Anaplastic Large Cell Lymphoma; Stage III Childhood Hodgkin Lymphoma; Stage III Childhood Large Cell Lymphoma; Stage III Childhood Lymphoblastic Lymphoma; Stage III Childhood Small Noncleaved Cell Lymphoma; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Small Lymphocytic Lymphoma; Stage IIIA Mycosis Fungoides/Sezary Syndrome; Stage IIIB Mycosis Fungoides/Sezary Syndrome; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Hodgkin Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Childhood Anaplastic Large Cell Lymphoma; Stage IV Childhood Hodgkin Lymphoma; Stage IV Childhood Large Cell Lymphoma; Stage IV Childhood Lymphoblastic Lymphoma; Stage IV Childhood Small Noncleaved Cell Lymphoma; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Small Lymphocytic Lymphoma; Stage IVA Mycosis Fungoides/Sezary Syndrome; Stage IVB Mycosis Fungoides/Sezary Syndrome; T-cell Large Granular Lymphocyte Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia |
Case Comprehensive Cancer Center |
2014-03 | EARLY_PHASE1 |
| NCT01178658 | UNKNOWN | Non-Hodgkin Lymphoma |
Seoul National University Hospital |
2010-07 | PHASE2 |
| NCT01800643 | UNKNOWN | Acute Leukemia; Chronic Leukemia; Lymphoproliferative Disease; Myeloproliferative Disease; Immunodeficiency |
Hospital Israelita Albert Einstein |
2010-03 | PHASE2; PHASE3 |
| NCT01255527 | UNKNOWN | Multiple Myeloma Patients Who Candidate for Autologous Peripheral Blood Stem Cell Transplantation |
Yonsei University |
2010-10 | PHASE1; PHASE2 |
| NCT00469144 | COMPLETED | Myelodysplastic Syndrome; Leukemia; Acute Myeloid Leukemia |
M.D. Anderson Cancer Center |
2005-06 | PHASE3 |
| NCT01390402 | COMPLETED | Leukemia; Chronic Myelogenous Leukemia |
M.D. Anderson Cancer Center |
2012-01 | PHASE2 |
| NCT01457885 | COMPLETED | Acute Myeloblastic Leukemia |
University of Michigan Rogel Cancer Center |
2011-11 | PHASE2 |
| NCT00802113 | COMPLETED | Non-Hodgkin's Lymphoma; Hodgkins Disease |
Columbia University |
2003-06 | PHASE1; PHASE2 |
| NCT01746173 | TERMINATED | T-cell Non-Hodgkin Lymphoma |
Dana-Farber Cancer Institute |
2013-07 | PHASE2 |
| NCT00813124 | COMPLETED | Stem Cell Transplantation; Leukemia |
M.D. Anderson Cancer Center |
2008-12 | PHASE2 |
| NCT01063439 | UNKNOWN | Non Hodgkin's Lymphoma |
Inje University |
2010-01 | PHASE2 |
| NCT00796562 | COMPLETED | MDS; Leukemias; Lymphomas |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2008-12 | PHASE2 |
| NCT02007863 | COMPLETED | Leukemia; Myelodysplasia; Acute Lymphocytic Leukemia; Acute Myelogenous Leukemia |
University of Miami |
2008-08 | |
| NCT01427881 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Myeloid Leukemia in Remission; Adult Erythroleukemia (M6a); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Adult Pure Erythroid Leukemia (M6b); Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Childhood Acute Erythroleukemia (M6); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Myeloid Leukemia in Remission; Childhood Burkitt Lymphoma; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Noncutaneous Extranodal Lymphoma; Peripheral T-cell Lymphoma; Philadelphia Chromosome Negative Chronic Myelogenous Leukemia; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Recurrent/Refractory Childhood Hodgkin Lymphoma; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage III Multiple Myeloma; Testicular Lymphoma; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2011-09 | PHASE2 |
| NCT01339988 | UNKNOWN | Acute Leukemias; Chronic Leukemias; Myelodysplastic Syndrome; Juvenile Myelomonocytic Leukemia |
Tel-Aviv Sourasky Medical Center |
2011-06 | PHASE4 |
| NCT01749293 | TERMINATED | Hematologic Malignancies |
University of Illinois at Chicago |
2012-08-30 | PHASE2 |
| NCT00907582 | TERMINATED | Acute Promyelocytic Leukemia; Relapse |
Shanghai Jiao Tong University School of Medicine |
2009-06 | PHASE2 |
| NCT00691015 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Barbara Ann Karmanos Cancer Institute |
2008-05 | PHASE2 |
| NCT00997386 | COMPLETED | Hematologic Neoplasms; Multiple Myeloma; Anemia, Aplastic; Hemoglobinuria, Paroxysmal; Myelofibrosis |
University of Arizona |
2009-09 | PHASE2 |
| NCT00317408 | UNKNOWN | Lymphoma |
European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma |
2004-04 | |
| NCT01622556 | TERMINATED | Hematologic Malignancies |
University of Virginia |
2012-01 | PHASE2 |
| NCT01181271 | COMPLETED | Diffuse, Large B-Cell, Lymphoma; Lymphoma, Low-Grade; T-Cell Lymphoma; Mantle-Cell Lymphoma; Hodgkin's Lymphoma; Chronic Lymphocytic Leukemia; Lymphoma, Small Lymphocytic |
Massachusetts General Hospital |
2010-08 | PHASE2 |
| NCT00179764 | COMPLETED | Tumors; Malignant Melanoma; Hematological Malignancies; Myelogenous Leukemia, Chronic; Leukemia, Lymphoblastic, Acute |
Ann & Robert H Lurie Children's Hospital of Chicago |
2000-03-10 | |
| NCT01923935 | UNKNOWN | Multiple Myeloma |
Chonnam National University Hospital |
2013-01 | PHASE2 |
| NCT01048827 | COMPLETED | Acute Myeloid Leukemia |
University of California, San Francisco |
2009-11 | PHASE1 |
| NCT01338675 | UNKNOWN | Chronic Granulomatous Disease |
Seoul National University Hospital |
2011-01 | PHASE1; PHASE2 |
| NCT01455506 | COMPLETED | Acute Myeloid Leukemia; Myelodysplastic Syndrome |
Hackensack Meridian Health |
2009-05 | PHASE1 |
| NCT00731328 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Nonmalignant Neoplasm; Paroxysmal Nocturnal Hemoglobinuria |
Asan Medical Center |
2008-04 | PHASE2 |
| NCT01274195 | UNKNOWN | Hematopoietic Stem Cell Transplantation |
Seoul National University Hospital |
2011-01 | PHASE2 |
| NCT00843947 | COMPLETED | Hematologic Malignancies |
University of California, Davis |
2007-06 | PHASE2 |
| NCT01500161 | TERMINATED | Acute Myelogenous Leukemia; Acute Lymphocytic Leukemia; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia; Hodgkins Disease; Non-Hodgkins Lymphoma; Aplastic Anemia; Multiple Myeloma; Myelodysplastic Syndrome |
Texas Oncology Cancer Center |
2011-11 | PHASE2 |
| NCT01464359 | TERMINATED | Acute Myelogenous Leukemia; Refractory Acute Myelogenous Leukemia |
Masonic Cancer Center, University of Minnesota |
2011-10 | PHASE2 |
| NCT00619645 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
University of California, Davis |
2007-06 | PHASE2 |
| NCT01156350 | UNKNOWN | Neuroblastoma |
University Hospital, Clermont-Ferrand |
2011-09 | PHASE2 |
| NCT00623935 | COMPLETED | Acute Myelogenous Leukemia |
University of Michigan Rogel Cancer Center |
2007-03 | PHASE2 |
| NCT00863148 | COMPLETED | MDS; AML; ALL; BAL |
Nantes University Hospital |
2009-10 | PHASE2 |
| NCT00775931 | COMPLETED | Severe Osteopetrosis |
Masonic Cancer Center, University of Minnesota |
2008-08 | PHASE2; PHASE3 |
| NCT00496340 | COMPLETED | Hematologic Malignancies |
H. Lee Moffitt Cancer Center and Research Institute |
2007-07 | PHASE2 |
| NCT00513474 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Massachusetts General Hospital |
2008-01 | PHASE1 |
| NCT01044745 | TERMINATED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Myeloid Leukemia in Remission; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Blastic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Contiguous Stage II Adult Lymphoblastic Lymphoma; Contiguous Stage II Grade 1 Follicular Lymphoma; Contiguous Stage II Grade 2 Follicular Lymphoma; Contiguous Stage II Grade 3 Follicular Lymphoma; Contiguous Stage II Mantle Cell Lymphoma; Contiguous Stage II Marginal Zone Lymphoma; Contiguous Stage II Small Lymphocytic Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Graft Versus Host Disease; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Burkitt Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma; Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma; Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma; Noncontiguous Stage II Adult Lymphoblastic Lymphoma; Noncontiguous Stage II Grade 1 Follicular Lymphoma; Noncontiguous Stage II Grade 2 Follicular Lymphoma; Noncontiguous Stage II Grade 3 Follicular Lymphoma; Noncontiguous Stage II Mantle Cell Lymphoma; Noncontiguous Stage II Marginal Zone Lymphoma; Noncontiguous Stage II Small Lymphocytic Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Splenic Marginal Zone Lymphoma; Stage I Adult Burkitt Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Stage I Adult Diffuse Mixed Cell Lymphoma; Stage I Adult Diffuse Small Cleaved Cell Lymphoma; Stage I Adult Immunoblastic Large Cell Lymphoma; Stage I Adult Lymphoblastic Lymphoma; Stage I Adult T-cell Leukemia/Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage I Cutaneous T-cell Non-Hodgkin Lymphoma; Stage I Grade 1 Follicular Lymphoma; Stage I Grade 2 Follicular Lymphoma; Stage I Grade 3 Follicular Lymphoma; Stage I Mantle Cell Lymphoma; Stage I Marginal Zone Lymphoma; Stage I Mycosis Fungoides/Sezary Syndrome; Stage I Small Lymphocytic Lymphoma; Stage II Adult T-cell Leukemia/Lymphoma; Stage II Chronic Lymphocytic Leukemia; Stage II Cutaneous T-cell Non-Hodgkin Lymphoma; Stage II Mycosis Fungoides/Sezary Syndrome; Stage III Adult Burkitt Lymphoma; Stage III Adult Diffuse Large Cell Lymphoma; Stage III Adult Diffuse Mixed Cell Lymphoma; Stage III Adult Diffuse Small Cleaved Cell Lymphoma; Stage III Adult Immunoblastic Large Cell Lymphoma; Stage III Adult Lymphoblastic Lymphoma; Stage III Adult T-cell Leukemia/Lymphoma; Stage III Chronic Lymphocytic Leukemia; Stage III Cutaneous T-cell Non-Hodgkin Lymphoma; Stage III Grade 1 Follicular Lymphoma; Stage III Grade 2 Follicular Lymphoma; Stage III Grade 3 Follicular Lymphoma; Stage III Mantle Cell Lymphoma; Stage III Marginal Zone Lymphoma; Stage III Mycosis Fungoides/Sezary Syndrome; Stage III Small Lymphocytic Lymphoma; Stage IV Adult Burkitt Lymphoma; Stage IV Adult Diffuse Large Cell Lymphoma; Stage IV Adult Diffuse Mixed Cell Lymphoma; Stage IV Adult Diffuse Small Cleaved Cell Lymphoma; Stage IV Adult Immunoblastic Large Cell Lymphoma; Stage IV Adult Lymphoblastic Lymphoma; Stage IV Adult T-cell Leukemia/Lymphoma; Stage IV Chronic Lymphocytic Leukemia; Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma; Stage IV Grade 1 Follicular Lymphoma; Stage IV Grade 2 Follicular Lymphoma; Stage IV Grade 3 Follicular Lymphoma; Stage IV Mantle Cell Lymphoma; Stage IV Marginal Zone Lymphoma; Stage IV Mycosis Fungoides/Sezary Syndrome; Stage IV Small Lymphocytic Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia; Waldenström Macroglobulinemia |
University of Nebraska |
2009-12-10 | PHASE2 |
| NCT00669890 | TERMINATED | Acute Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome |
New York Medical College |
2004-05 | PHASE1 |
| NCT00084695 | UNKNOWN | Childhood Langerhans Cell Histiocytosis; Fanconi Anemia; Leukemia; Lymphoma; Myelodysplastic Syndromes; Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific |
Milton S. Hershey Medical Center |
2003-09 | PHASE2 |
| NCT00615589 | TERMINATED | Multiple Myeloma; Plasma Cell Leukemia |
University of Michigan Rogel Cancer Center |
2008-02 | PHASE2 |
| NCT00613561 | UNKNOWN | Severe Immunodeficiency Diseases |
Ann & Robert H Lurie Children's Hospital of Chicago |
2007-12 | PHASE2 |
| NCT01191957 | COMPLETED | Acute Myeloid Leukemia (AML) |
Gruppo Italiano Trapianto di Midollo Osseo |
2008-01 | PHASE3 |
| NCT01087398 | UNKNOWN | Osteopetrosis |
Tehran University of Medical Sciences |
2009-09 | PHASE2; PHASE3 |
| NCT01071486 | WITHDRAWN | Busulfan Pharmacokinetic Analysis; GST Genetic Polymorphism |
Rambam Health Care Campus |
2009-08 | PHASE4 |
| NCT00822770 | COMPLETED | Stem Cell Transplantation; Leukemia |
M.D. Anderson Cancer Center |
2009-01 | PHASE1; PHASE2 |
| NCT00410982 | COMPLETED | Leukemia; Lymphoma; Myeloma |
M.D. Anderson Cancer Center |
2006-12 | PHASE1 |
| NCT00454480 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
The University of New South Wales |
2006-08 | PHASE2; PHASE3 |
| NCT00578344 | TERMINATED | Sickle Cell Disease; Hemoglobin SC |
Tami D. John |
2005-07 | |
| NCT00623077 | TERMINATED | Brain and Central Nervous System Tumors; Kidney Cancer; Liver Cancer; Retinoblastoma; Sarcoma |
Masonic Cancer Center, University of Minnesota |
2005-08 | PHASE1 |
| NCT00874315 | WITHDRAWN | Neuroblastoma |
Nationwide Children's Hospital |
2008-09 | PHASE2 |
| NCT01135329 | TERMINATED | Lymphoma; Leukemia; Myelodysplastic Syndrome |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-08 | PHASE2 |
| NCT00887042 | UNKNOWN | Acute Myeloid Leukemia |
The Korean Society of Pediatric Hematology Oncology |
2006-06 | PHASE1; PHASE2 |
| NCT00322101 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Acute Myeloid Leukemia/Transient Myeloproliferative Disorder; Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Acute Myeloid Leukemia in Remission; Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Myelodysplastic Syndrome With Isolated Del(5q); Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
2006-01 | PHASE3 |
| NCT01009840 | COMPLETED | Multiple Myeloma |
Otsuka Pharmaceutical Development & Commercialization, Inc. |
2010-05-01 | PHASE2 |
| NCT01118013 | TERMINATED | Leukemia; Lymphoma; Lymphoproliferative Disorder; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Alliance for Clinical Trials in Oncology |
2010-12 | PHASE2 |
| NCT00885833 | COMPLETED | Wiskott-Aldrich Syndrome |
The Korean Society of Pediatric Hematology Oncology |
2007-02 | PHASE1; PHASE2 |
| NCT00934232 | TERMINATED | Multiple Myeloma |
Guido Tricot |
2009-08 | PHASE1 |
| NCT00176839 | TERMINATED | Leukemia, Lymphocytic, Acute; AML; MDS |
Masonic Cancer Center, University of Minnesota |
2000-06-07 | PHASE2; PHASE3 |
| NCT01018446 | COMPLETED | Hematopoietic Stem Cell Transplantation |
Seoul National University Hospital |
2008-12 | PHASE1 |
| NCT00328029 | UNKNOWN | Signs and Symptoms, Respiratory |
University Hospital, Strasbourg, France |
2006-07 | PHASE2 |
| NCT00841724 | COMPLETED | Hematological Malignancies |
Nantes University Hospital |
2009-01 | PHASE2 |
| NCT00020566 | UNKNOWN | Sarcoma |
University of Leicester |
2001-02 | PHASE3 |
| NCT00815568 | UNKNOWN | AML; MDS; ALL; CML; Lymphoma |
Samsung Medical Center |
2008-08 | PHASE2 |
| NCT03792815 | COMPLETED | Non-Hodgkin's Lymphoma |
Soonchunhyang University Hospital |
2009-10 | PHASE2 |
| NCT00054327 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
2000-11 | PHASE2 |
| NCT01359254 | TERMINATED | Hematological Disease |
University of Chicago |
2010-04 | PHASE2 |
| NCT00301834 | COMPLETED | Congenital Amegakaryocytic Thrombocytopenia; Diamond-blackfan Anemia; Leukemia; Myelodysplastic Syndromes; Severe Congenital Neutropenia |
University of California, San Francisco |
2005-01 | PHASE2 |
| NCT00506857 | COMPLETED | Hematologic Malignancies |
M.D. Anderson Cancer Center |
2003-11 | PHASE1; PHASE2 |
| NCT00478244 | TERMINATED | Epidermolysis Bullosa |
Masonic Cancer Center, University of Minnesota |
2007-04 | |
| NCT00852163 | COMPLETED | Leukemia; Myelodysplastic Syndrome |
Baylor Research Institute |
2007-03 | PHASE2 |
| NCT01020539 | COMPLETED | Acute Myelogenous Leukemia; Myelodysplastic Syndrome; Juvenile Myelomonocytic Leukemia |
Columbia University |
2002-09-11 | PHASE1 |
| NCT00598481 | COMPLETED | Immunologic Deficiency Syndromes |
Fondazione Telethon |
2002-10-02 | PHASE2 |
| NCT00445744 | COMPLETED | Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Childhood Acute Myeloid Leukemia in Remission; Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Essential Thrombocythemia; Myelodysplastic Syndrome With Isolated Del(5q); Polycythemia Vera; Previously Treated Myelodysplastic Syndromes; Primary Myelofibrosis; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Secondary Myelofibrosis; Untreated Adult Acute Myeloid Leukemia; Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies |
Fred Hutchinson Cancer Center |
2006-12 | |
| NCT00556452 | COMPLETED | Leukemia; Hodgkin Lymphoma; Non-Hodgkin Lymphoma; Multiple Myeloma; Myelodysplastic Syndrome |
University of Michigan Rogel Cancer Center |
2007-10 | PHASE1; PHASE2 |
| NCT00540995 | TERMINATED | Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Blastic Phase Chronic Myelogenous Leukemia; Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Myeloid Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Refractory Anemia With Excess Blasts |
City of Hope Medical Center |
2007-06-11 | PHASE1; PHASE2 |
| NCT00802568 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Institut Paoli-Calmettes |
2007-04 | PHASE2 |
| NCT00840684 | COMPLETED | Leukemia |
Institut Paoli-Calmettes |
2009-01 | PHASE1; PHASE2 |
| NCT00806767 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Institut Paoli-Calmettes |
2007-03 | PHASE2 |
| NCT00782379 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes |
Northside Hospital, Inc. |
2008-10 | PHASE2 |
| NCT00818961 | TERMINATED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Northside Hospital, Inc. |
2005-05 | PHASE2 |
| NCT00416598 | COMPLETED | Acute Myeloid Leukemia; Acute Myeloid Leukemia With Myelodysplasia-Related Changes; Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11; Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1; Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A; Untreated Adult Acute Myeloid Leukemia |
National Cancer Institute (NCI) |
2006-11-15 | PHASE2 |
| NCT00448201 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
UNC Lineberger Comprehensive Cancer Center |
2011-01-07 | PHASE2 |
| NCT00670410 | TERMINATED | Neuroblastoma |
Columbia University |
2003-11 | PHASE1 |
| NCT00477542 | COMPLETED | Hematologic Malignancies |
Indiana University |
2007-05 | PHASE1 |
| NCT00427765 | COMPLETED | Multiple Myeloma; Lymphoma |
M.D. Anderson Cancer Center |
2004-12 | PHASE2 |
| NCT00334672 | UNKNOWN | Nonneoplastic Condition |
Children's Cancer and Leukaemia Group |
2006-03 | PHASE3 |
| NCT00836628 | WITHDRAWN | Refractory Brain Tumors |
Ann & Robert H Lurie Children's Hospital of Chicago |
2008-07 | PHASE1 |
| NCT00555048 | TERMINATED | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
2007-09 | PHASE1; PHASE2 |
| NCT00787761 | COMPLETED | Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Northside Hospital, Inc. |
2007-04 | PHASE2 |
| NCT00176904 | COMPLETED | Adrenoleukodystrophy; Metachromatic Leukodystrophy; Globoid Cell Leukodystrophy; Gaucher's Disease; Fucosidosis; Wolman Disease; Niemann-Pick Disease; Batten Disease; GM1 Gangliosidosis; Tay Sachs Disease; Sandhoff Disease |
Masonic Cancer Center, University of Minnesota |
1995-01 | PHASE2; PHASE3 |
| NCT00627666 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Asan Medical Center |
2003-01 | PHASE2 |
| NCT00179790 | COMPLETED | Leukemia; Cancer |
Ann & Robert H Lurie Children's Hospital of Chicago |
2005-07 | PHASE1; PHASE2 |
| NCT00534430 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
City of Hope Medical Center |
2000-02-29 | PHASE2 |
| NCT00265889 | COMPLETED | Lymphoma |
Case Comprehensive Cancer Center |
2002-02 | PHASE2 |
| NCT00112645 | COMPLETED | Neuroblastoma; Sarcoma; Unspecified Childhood Solid Tumor, Protocol Specific |
Milton S. Hershey Medical Center |
2005-04 | PHASE1 |
| NCT00804947 | UNKNOWN | Multiple Myeloma |
Fundacion Para La Investigacion Hospital La Fe |
2005-09 | PHASE2 |
| NCT00134017 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2004-06 | PHASE2 |
| NCT00668564 | TERMINATED | Hurler's Syndrome; Maroteaux-Lamy Syndrome; Sly Syndrome; Alpha Mannosidosis; Fucosidosis; Aspartylglucosaminuria; Sphingolipidoses; Krabbe Disease; Wolman's Disease; Niemann-Pick Disease Type B; Niemann-Pick Disease, Type C |
Masonic Cancer Center, University of Minnesota |
2008-03 | PHASE2 |
| NCT00740467 | UNKNOWN | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Precancerous Condition |
Institut Paoli-Calmettes |
2008-01 | PHASE2 |
| NCT00003199 | COMPLETED | Estrogen Receptor-negative Breast Cancer; Estrogen Receptor-positive Breast Cancer; Inflammatory Breast Cancer; Male Breast Cancer; Progesterone Receptor-negative Breast Cancer; Progesterone Receptor-positive Breast Cancer; Stage IIIB Breast Cancer; Stage IV Breast Cancer |
Fred Hutchinson Cancer Center |
1997-11 | PHASE2 |
| NCT00732316 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
Asan Medical Center |
2008-04 | PHASE2 |
| NCT00547196 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes |
City of Hope Medical Center |
2005-08-16 | |
| NCT00499889 | TERMINATED | Leukemia |
M.D. Anderson Cancer Center |
2003-02 | PHASE2 |
| NCT00774280 | COMPLETED | Leukemia; Myelodysplastic Syndrome |
Cooperative Study Group A for Hematology |
2002-05 | PHASE3 |
| NCT00357396 | COMPLETED | Sarcoma |
Memorial Sloan Kettering Cancer Center |
2005-06 | PHASE2 |
| NCT00113919 | TERMINATED | Multiple Myeloma |
University of Arkansas |
2004-06 | PHASE1; PHASE2 |
| NCT00795132 | COMPLETED | Acute Leukaemia; Chronic Disease; Leukemia; Myelodysplasia; Lymphoma |
University of Utah |
2004-04 | PHASE2 |
| NCT00301951 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
University of California, San Francisco |
2004-09 | PHASE1 |
| NCT00801931 | TERMINATED | Leukemia; Lymphoma; Neuroblastoma; Immunodeficiencies; Anemia |
Columbia University |
2007-09-06 | PHASE1; PHASE2 |
| NCT00363467 | TERMINATED | Acute Myeloid Leukemia (AML) |
H. Lee Moffitt Cancer Center and Research Institute |
2006-05 | |
| NCT00750126 | UNKNOWN | Solid Tumors; Hematologic Neoplasms |
University Hospital, Clermont-Ferrand |
2007-04 | PHASE2 |
| NCT00186966 | COMPLETED | Acute Myeloid Leukemia |
Dutch Childhood Oncology Group |
2002-03 | PHASE3 |
| NCT00176878 | COMPLETED | Diamond-Blackfan Anemia; Kostmann's Neutropenia; Shwachman-Diamond Syndrome |
Masonic Cancer Center, University of Minnesota |
2000-06 | PHASE2; PHASE3 |
| NCT00304018 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
University of California, San Francisco |
2002-10 | PHASE1 |
| NCT00049517 | COMPLETED | Leukemia |
Eastern Cooperative Oncology Group |
2002-12-19 | PHASE3 |
| NCT00785330 | COMPLETED | Non-Hodgkin's Lymphoma |
Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH |
2004-04 | PHASE2 |
| NCT00579111 | TERMINATED | Myelodysplastic and Myeloproliferative Disorders; Acute Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Myelogenous Leukemia; Multiple Myeloma; Plasma Cell Dyscrasia; Lymphoproliferative Disorders; Hematologic Diseases |
Baylor College of Medicine |
2007-06 | PHASE1; PHASE2 |
| NCT00186342 | COMPLETED | Acute Disease; Myelodysplastic Syndromes; Leukemia, Myeloid, Chronic; Myeloproliferative Disorders; Blood and Marrow Transplant (BMT); Myelodysplastic Syndromes (MDS); Leukemia |
Stanford University |
1992-09 | |
| NCT00502905 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
2003-10 | PHASE2 |
| NCT00578435 | COMPLETED | Genetic Disorders; Sickle Cell Anemia |
Memorial Sloan Kettering Cancer Center |
1994-01 | PHASE2 |
| NCT00684255 | TERMINATED | Systemic Lupus Erythematosus; Systemic Sclerosis |
New York Medical College |
2007-08 | PHASE1 |
| NCT00521430 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Nonmalignant Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific |
Asan Medical Center |
2004-04 | |
| NCT00176917 | COMPLETED | Mucopolysaccharidosis I; Mucopolysaccharidosis VI; Mannosidosis; Mucolipidosis Type II (I-cell Disease) |
Masonic Cancer Center, University of Minnesota |
1999-05 | PHASE2 |
| NCT00611351 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Secondary Myelofibrosis |
University of Nebraska |
2005-06-07 | PHASE2 |
| NCT00281879 | TERMINATED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Unusual Cancers of Childhood |
OHSU Knight Cancer Institute |
2006-02 | PHASE2 |
| NCT00004128 | UNKNOWN | Leukemia |
European Organisation for Research and Treatment of Cancer - EORTC |
1999-09 | PHASE3 |
| NCT00245115 | TERMINATED | Leukemia |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-10 | PHASE1 |
| NCT00531310 | TERMINATED | Chronic Myeloid Leukemia |
Columbia University |
2003-01 | PHASE2 |
| NCT00003335 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
1998-01 | PHASE2 |
| NCT00301912 | WITHDRAWN | Anemia; Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
University of California, San Francisco |
2002-01 | PHASE2 |
| NCT00007995 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Herbert Irving Comprehensive Cancer Center |
1999-07 | PHASE2 |
| NCT00208923 | COMPLETED | Hematologic Malignancies |
Emory University |
1998-07 | PHASE2 |
| NCT00313625 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Fred Hutchinson Cancer Center |
2005-09 | PHASE2 |
| NCT00005797 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Multiple Myeloma and Malignant Plasma Cell Neoplasms; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
H. Lee Moffitt Cancer Center and Research Institute |
1993-03 | PHASE2 |
| NCT00296023 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
University of California, San Francisco |
1999-01 | |
| NCT00014469 | COMPLETED | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Memorial Sloan Kettering Cancer Center |
2000-12 | PHASE2 |
| NCT00290628 | TERMINATED | Chronic Myeloproliferative Disorders; Diamond-blackfan Anemia; Fanconi Anemia; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Masonic Cancer Center, University of Minnesota |
1999-10 | |
| NCT00049634 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
2002-01 | PHASE1; PHASE2 |
| NCT00002761 | WITHDRAWN | Leukemia |
Columbia University |
1996-02 | PHASE1; PHASE2 |
| NCT00077116 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
European Organisation for Research and Treatment of Cancer - EORTC |
2003-11 | PHASE2 |
| NCT00053196 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma; Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myeloproliferative Neoplasms |
Alliance for Clinical Trials in Oncology |
2002-12 | PHASE2 |
| NCT00070174 | COMPLETED | Leukemia |
Children's Oncology Group |
2003-12 | PHASE2 |
| NCT00002798 | COMPLETED | Childhood Acute Erythroleukemia (M6); Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloblastic Leukemia With Maturation (M2); Childhood Acute Myeloblastic Leukemia Without Maturation (M1); Childhood Acute Myelomonocytic Leukemia (M4); Childhood Myelodysplastic Syndromes; Chronic Myelomonocytic Leukemia; de Novo Myelodysplastic Syndromes; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Excess Blasts in Transformation; Refractory Anemia With Ringed Sideroblasts; Secondary Myelodysplastic Syndromes; Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies |
National Cancer Institute (NCI) |
1996-08 | PHASE3 |
| NCT00004231 | COMPLETED | Lymphoma |
Northwestern University |
1999-10 | PHASE2 |
| NCT00060255 | COMPLETED | Breast Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific |
Roswell Park Cancer Institute |
1991-12 | PHASE2 |
| NCT00029380 | COMPLETED | Hematologic Diseases; Anemia, Sickle Cell; Beta-Thalassemia; Hematopoietic Stem Cell Transplantation |
National Heart, Lung, and Blood Institute (NHLBI) |
1999-01 | PHASE2 |
| NCT00003116 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
1997-05 | PHASE2 |
| NCT00186810 | COMPLETED | Sickle Cell Disease |
St. Jude Children's Research Hospital |
1992-12 | PHASE2 |
| NCT00005940 | COMPLETED | Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) |
Fred Hutchinson Cancer Center |
1999-10 | PHASE2 |
| NCT00003336 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
1998-01 | PHASE2 |
| NCT00008190 | COMPLETED | Leukemia |
Herbert Irving Comprehensive Cancer Center |
1999-03 | PHASE2 |
| NCT00152126 | COMPLETED | Neuroblastoma; Central Nervous System Tumors; Lymphomas; Wilms Tumor |
St. Jude Children's Research Hospital |
2003-08 | |
| NCT00003913 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
1998-12 | PHASE2 |
| NCT00006363 | COMPLETED | Adult Acute Basophilic Leukemia; Adult Acute Eosinophilic Leukemia; Adult Acute Erythroid Leukemia (M6); Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Erythroleukemia (M6a); Adult Pure Erythroid Leukemia (M6b); Childhood Acute Basophilic Leukemia; Childhood Acute Eosinophilic Leukemia; Childhood Acute Erythroleukemia (M6); Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Minimally Differentiated Myeloid Leukemia (M0); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monoblastic Leukemia and Acute Monocytic Leukemia (M5); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloblastic Leukemia With Maturation (M2); Childhood Acute Myeloblastic Leukemia Without Maturation (M1); Childhood Acute Myelomonocytic Leukemia (M4); Childhood Myelodysplastic Syndromes; de Novo Myelodysplastic Syndromes; Untreated Adult Acute Myeloid Leukemia; Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies |
National Cancer Institute (NCI) |
2000-11 | PHASE3 |
| NCT00043810 | TERMINATED | Acute Myelogenous Leukemia; Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2002-07 | PHASE1; PHASE2 |
| NCT00005986 | TERMINATED | Leukemia |
Masonic Cancer Center, University of Minnesota |
2000-08 | PHASE2 |
| NCT00004896 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Northwestern University |
1999-10 | PHASE2 |
| NCT00004907 | COMPLETED | Lymphoma |
Northwestern University |
1999-10 | PHASE1; PHASE2 |
| NCT00004181 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm |
Northwestern University |
1999-10 | PHASE2 |
| NCT00305708 | COMPLETED | Congenital Amegakaryocytic Thrombocytopenia; Diamond-blackfan Anemia; Fanconi Anemia; Leukemia; Severe Congenital Neutropenia; Thrombocytopenia |
University of California, San Francisco |
2000-08 | PHASE1; PHASE2 |
| NCT00005824 | COMPLETED | Lymphoma |
AIDS Malignancy Consortium |
2000-11 | PHASE2 |
| NCT00003414 | COMPLETED | Graft Versus Host Disease; Lymphoma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1997-10 | PHASE3 |
| NCT00005866 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
SWOG Cancer Research Network |
2000-02 | PHASE3 |
| NCT00002868 | COMPLETED | Leukemia |
Eastern Cooperative Oncology Group |
1997-11-20 | PHASE3 |
| NCT00040469 | TERMINATED | Sickle Cell Anemia; Hemoglobinopathy; Thalassemia |
Baylor College of Medicine |
2000-08 | PHASE2 |
| NCT00034528 | TERMINATED | Hemoglobinopathies; Anemia, Sickle Cell; Hemoglobin SC Disease; Thalassemia; Thalassemia Major |
National Institute of Allergy and Infectious Diseases (NIAID) |
2001-09 | PHASE2 |
| NCT00002547 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
Barbara Ann Karmanos Cancer Institute |
1987-08 | PHASE2 |
| NCT00055653 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic-Myeloproliferative Diseases |
Roswell Park Cancer Institute |
2003-01 | PHASE2 |
| NCT00006246 | COMPLETED | Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Leukemia; Lymphoma; Metastatic Cancer; Retinoblastoma; Sarcoma |
Pediatric Brain Tumor Consortium |
2000-11 | PHASE1 |
| NCT00002792 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
1996-06 | PHASE2 |
| NCT00003972 | COMPLETED | Breast Cancer |
Fred Hutchinson Cancer Center |
1998-07 | PHASE3 |
| NCT00002768 | COMPLETED | Leukemia |
Alliance for Clinical Trials in Oncology |
1996-06 | PHASE2 |
| NCT00002831 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
1995-08-01 | PHASE1; PHASE2 |
| NCT00006054 | TERMINATED | Immunologic Deficiency Syndromes; Chediak-Higashi Syndrome; Common Variable Immunodeficiency; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; Hemophagocytic Lymphohistiocytosis; X-linked Agammaglobulinemia; Wiskott-Aldrich Syndrome; Chronic Granulomatous Disease; X-linked Hyper IgM Syndrome; Severe Combined Immunodeficiency; Leukocyte Adhesion Deficiency Syndrome; Virus-Associated Hemophagocytic Syndrome |
Fairview University Medical Center |
2000-03 | |
| NCT00002592 | COMPLETED | Leukemia |
Abramson Cancer Center at Penn Medicine |
1993-06 | PHASE2 |
| NCT00003926 | TERMINATED | Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Chordoma; Kidney Cancer; Liver Cancer; Neuroblastoma; Ovarian Cancer; Retinoblastoma; Sarcoma |
Masonic Cancer Center, University of Minnesota |
1998-11 | PHASE1 |
| NCT00003081 | COMPLETED | Sarcoma |
Fred Hutchinson Cancer Center |
1998-03 | PHASE1 |
| NCT00005948 | COMPLETED | Leukemia |
Fred Hutchinson Cancer Center |
2000-01 | PHASE2 |
| NCT00003960 | COMPLETED | Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1998-04 | PHASE2 |
| NCT00003146 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Fred Hutchinson Cancer Center |
1997-11 | PHASE2 |
| NCT00006126 | WITHDRAWN | Breast Cancer; Kidney Cancer; Lung Cancer; Melanoma (Skin); Testicular Germ Cell Tumor |
Northwestern University |
1999-09 | PHASE1 |
| NCT00002961 | TERMINATED | Leukemia |
Children's Hospital of Philadelphia |
1995-10 | PHASE3 |
| NCT00003462 | COMPLETED | Brain and Central Nervous System Tumors |
Duke University |
1998-04 | PHASE1 |
| NCT00005641 | TERMINATED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
H. Lee Moffitt Cancer Center and Research Institute |
1997-09 | PHASE2 |
| NCT00705120 | COMPLETED | Osteogenesis Imperfecta |
St. Jude Children's Research Hospital |
1995-11 | PHASE1 |
| NCT00002502 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Memorial Sloan Kettering Cancer Center |
1992-07 | PHASE2 |
| NCT01177371 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With T(15;17)(q22;q12); Adult Acute Myeloid Leukemia With T(16;16)(p13;q22); Adult Acute Myeloid Leukemia With T(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Acute Promyelocytic Leukemia (M3); Adult Erythroleukemia (M6a); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Adult Pure Erythroid Leukemia (M6b); Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Burkitt Lymphoma; Childhood Acute Erythroleukemia (M6); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloblastic Leukemia With Maturation (M2); Childhood Acute Myeloblastic Leukemia Without Maturation (M1); Childhood Acute Myeloid Leukemia in Remission; Childhood Acute Myelomonocytic Leukemia (M4); Childhood Acute Promyelocytic Leukemia (M3); Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; De Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-Cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult Non-Hodgkin Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia |
Case Comprehensive Cancer Center |
1988-03 | PHASE2 |
| NCT00002554 | COMPLETED | Leukemia |
Fred Hutchinson Cancer Center |
1993-11 | PHASE2 |
| NCT00003661 | COMPLETED | Graft Versus Host Disease; Leukemia; Lymphoma; Myelodysplastic Syndromes; Neuroblastoma |
Roswell Park Cancer Institute |
1998-06 | PHASE2 |
| NCT00667927 | COMPLETED | Acute Myeloid Leukemia |
St. Jude Children's Research Hospital |
1991-03 | PHASE1 |
| NCT00030719 | UNKNOWN | Neuroblastoma |
University of Leicester |
2001-12 | PHASE3 |
| NCT00226512 | WITHDRAWN | Acute Myeloid Leukemia; Myelodysplastic Syndrome |
Hadassah Medical Organization |
2004-07 | PHASE3 |
| NCT00156858 | UNKNOWN | Hematologic Malignancy |
Alberta Health services |
1998-01 | |
| NCT00006056 | UNKNOWN | Chediak-Higashi Syndrome; Graft Versus Host Disease; X-Linked Lymphoproliferative Syndrome; Familial Erythrophagocytic Lymphohistiocytosis; Hemophagocytic Lymphohistiocytosis; Virus-Associated Hemophagocytic Syndrome |
Fairview University Medical Center |
2000-03 | |
| NCT00006367 | COMPLETED | Chronic Myeloproliferative Disorders |
Fred Hutchinson Cancer Center |
2000-05 | PHASE2 |
| NCT00025649 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00005893 | COMPLETED | Neutropenia; Sickle Cell Anemia; Thalassemia Major; Red-Cell Aplasia, Pure |
Fairview University Medical Center |
2000-06 | |
| NCT00024050 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
2001-02 | PHASE2 |
| NCT00003195 | COMPLETED | Multiple Myeloma and Plasma Cell Neoplasm |
Fred Hutchinson Cancer Center |
1997-12 | PHASE2 |
| NCT00081055 | WITHDRAWN | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes |
Mesoblast International Sàrl |
PHASE2 | |
| NCT00002771 | UNKNOWN | Leukemia |
German CML Study Group |
1995-01 | PHASE3 |
| NCT00027937 | COMPLETED | Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific; Unspecified Childhood Solid Tumor, Protocol Specific |
Fred Hutchinson Cancer Center |
2001-08 | PHASE2 |
| NCT00025402 | UNKNOWN | Leukemia |
III. Medizinische Klinik Mannheim |
1997-07 | PHASE3 |
| NCT00024193 | UNKNOWN | Neuroblastoma |
Children's Cancer and Leukaemia Group |
1999-04 | PHASE2 |
| NCT00228852 | COMPLETED | T-Cell Immune Deficiency Diseases; Severe Combined Immunodeficiency |
Emory University |
PHASE1; PHASE2 | |
| NCT00436761 | UNKNOWN | Unspecified Childhood Solid Tumor, Protocol Specific |
Milton S. Hershey Medical Center |
2004-05 | PHASE1 |
| NCT00516152 | COMPLETED | Chronic Myeloid Leukemia; Acute Myelogenous Leukemia; Myelodysplasia; Acute Lymphocytic Leukemia; Severe Aplastic Anemia; Non-Hodgkin's Lymphoma; Lymphoproliferative Disease; Multiple Myeloma; Advanced Myeloproliferative Disease |
University of California, San Francisco |
2002-11 | PHASE2 |
| NCT00281983 | COMPLETED | Chronic Lymphocytic Leukemia |
German CLL Study Group |
2000-06 | PHASE1; PHASE2 |
| NCT00003619 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic Syndromes; Thrombocytopenia |
Drexel University College of Medicine |
1998-02 | PHASE1; PHASE2 |
| NCT00054340 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
2002-10 | PHASE1; PHASE2 |
| NCT00295997 | UNKNOWN | Chronic Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
University of California, San Francisco |
2005-05 | |
| NCT00417053 | UNKNOWN | Neuroblastoma |
Children's Cancer and Leukaemia Group |
PHASE3 | |
| NCT00002701 | UNKNOWN | Leukemia |
European Organisation for Research and Treatment of Cancer - EORTC |
1995-10 | PHASE3 |
(data from https://clinicaltrials.gov, updated on 2026-02-13)
Check the
Busulfan
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
Note: Technical data last updated: Sep 1, 2026.